Global EEG Devices for Sleep and Sleep Architecture Market By Channels (1 Channel, 4 Channels, pay-per-use + 5 or 14 channels, 8-16 Channels, Above 16 Channels); By Offering (Products – Partially or fully Flexible Systems, Headcaps/ Headsets, Fixed Units, Others, Solution and Services); By End Use (Research and Universities, In-Home, Hospital/ Clinics, Business (Employers), Others); By Application (Clinical – Insomnia, Hypersomnia, Other non-OSA sleep disorders, Research – REM sleep without Atonia in patients with RBD, Predromal sleep biomarkers for neurodegenerative disease, Effect of Suvorexant progressive supranuclear palsy, Sleep patterns in patients with ICU delirium, Sleep quality changes as a result of cannabis and opioid dependency, Outcomes resulting from an insomnia intervention, Influence of sleep deprivation on memory, Others, Positional Sleep Apnea Therapy, Assess Sleep Architecture and Continuity, Others); By Region (U.S., Canada, Mexico, Rest of North America, France, UK, Germany, Spain, Italy, Nordic Countries, Benelux Union, Rest of Europe, China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia, Rest of Asia Pacific, Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of MEA, Brazil, Argentina, Rest of Latin America) – Global Insights, Growth, Size, Comparative Analysis, Trends and Forecast, 2022 – 2030
Industry Trends
Global EEG devices for sleep and sleep architecture market is growing at an estimated CAGR of 22.4% over the forecast period. Good and sound sleep is a guarantee of a great health. Newer type of devices have flooded the market. EEG devices are rapidly carving a niche for themselves. The technology helps map changes in brain activity that is likely to be useful in diagnosing brain conditions, including epilepsy and disorders related to seizure. An electroencephalogram (EEG) happens to be a test that keeps a track and then measures electrical activity in the brain with the help of small, metal discs (electrodes) that are linked to the scalp. The demand for EEG devices for sleep is constantly going upwards and thus helping the global EEG devices for sleep and sleep architecture market is growing.
The growth of the global EEG devices for sleep and sleep architecture market was hampered during the coronavirus pandemic. Courtesy of the trade restrictions imposed to curtail the spread of the infection adversely impacted the demand for the EEG devices.
By Channels
On the basis of channel, the global EEG devices for sleep and sleep architecture market has been bifurcated into 1 Channel, 4 Channels, pay-per-use + 5 or 14 channels, 8-16 Channels, and above 16 Channels. The pay-per-use segment is accounting for majority of the revenue generated by this market.
Global EEG Devices for Sleep and Sleep Architecture Market Revenue & Forecast, (US$ Million), 2022 – 2030
By Offering
On the basis of offering, the global EEG devices for sleep and sleep architecture market has been bifurcated into products and solution & services. The products segment has been further divided into partially or fully flexible systems, headcaps/ headsets, fixed Units, and others. The headcaps/ headsets are a hot selling property in today’s time and hence majority of money for this market.
By End Use
On the basis of end use, the global EEG devices for sleep and sleep architecture market has been divided into research and universities, in-home, hospital/ clinics, business (employers), and others. The research and universities segment at present has edge over other segments as the full potential of these devices hasn’t been tapped yet, hence several research institutes and universities are buying it on large scale.
By Application
On the basis of the application, the global EEG devices for sleep and sleep architecture market has been bifurcated into clinical, research, positional sleep apnea therapy, assess sleep architecture and continuity, and others. The clinical segment has been further divided into insomnia, hypersomnia, and other non-OSA sleep disorders. On the other hand, the research category is further categorised into REM sleep without atonia in patients with RBD, prodromal sleep biomarkers for neurodegenerative disease, effect of Suvorexant progressive supranuclear palsy, sleep patterns in patients with ICU delirium, sleep quality changes as a result of cannabis and opioid dependency, outcomes resulting from an insomnia intervention, Influence of sleep deprivation on memory, and others. The research category makes most of the money for this market as it is being determined how can these devices can be useful in treatment of certain diseases.
By Region
On the basis of region, the global EEG devices for sleep and sleep architecture market has been divided into Latin America, Europe, North America, Asia-Pacific and others. The region of North America has one of the most advanced healthcare infrastructure on this planet. Along with this, presence of top medical research companies in countries like the United States and Canada provides impetus to this market’s growth.
Competitive Landscape
The report provides both, qualitative and quantitative research of global EEG devices for sleep and sleep architecture market as well as provides comprehensive insights and development methods adopted by the key contenders. The report also offers extensive research on the key players in this market and details on the competitiveness of these players. Key business strategies such as mergers and acquisitions (M&A), affiliations, collaborations, and contacts adopted by these major market participants are also recognized and analysed in the report. For each company, the report studies their global presence, competitors, service offerings and specification amongst others.
Some of the major players operating in the global EEG devices for sleep and sleep architecture market are listed below:
- Advanced Brain Monitoring, Inc.
- Cognionics
- Dreem
- Emotiv
- Muse
- NeuroSky
- Other Market Participants
Global EEG Devices for Sleep and Sleep Architecture Market
By Channels
- 1 Channel
- 4 Channels
- pay-per-use + 5 or 14 channels
- 8-16 Channels
- Above 16 Channels
By Offering
- Products
- Partially or fully Flexible Systems
- Headcaps/ Headsets
- Fixed Units
- Others
- Solution and Services
By End Use
- Research and Universities
- In-Home
- Hospital/ Clinics
- Business (Employers)
- Others
By Application
- Clinical
- Insomnia
- Hypersomnia
- Other non-OSA sleep disorders
- Research
- REM sleep without Atonia in patients with RBD
- Predromal sleep biomarkers for neurodegenerative disease
- Effect of Suvorexant progressive supranuclear palsy
- Sleep patterns in patients with ICU delirium, Sleep quality changes as a result of cannabis and opioid dependency
- Outcomes resulting from an insomnia intervention, Influence of sleep deprivation on memory
- Others
- Positional Sleep Apnea Therapy
- Assess Sleep Architecture and Continuity
- Others
By Region
- North America
- S
- Canada
- Mexico
- Rest of North America
- Europe
- France
- The UK
- Spain
- Germany
- Italy
- Nordic Countries
- Denmark
- Finland
- Iceland
- Sweden
- Norway
- Benelux Union
- Belgium
- The Netherlands
- Luxembourg
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- New Zealand
- Australia
- South Korea
- Southeast Asia
- Indonesia
- Thailand
- Malaysia
- Singapore
- Rest of Southeast Asia
- Rest of Asia Pacific
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Kuwait
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Argentina
- Rest of Latin America
Table of
Contents
1.
Market Scope
1.1. Market Segmentation
1.2. Years Considered
1.2.1.
Historic Years: 2015 - 2020
1.2.2.
Base Year: 2021
1.2.3.
Forecast Years: 2022 – 2030
2.
Key Target Audiences
3.
Research Methodology
3.1. Primary Research
3.1.1. Research Questionnaire
3.1.2.
Global Percentage Breakdown
3.1.3.
Primary Interviews: Key Opinion Leaders
(KOLs)
3.2.
Secondary Research
3.2.1. Paid Databases
3.2.2.
Secondary Sources
3.3.
Market Size Estimates
3.3.1.
Top-Down Approach
3.3.2. Bottom-Up Approach
3.4.
Data Triangulation Methodology
3.5.
Research Assumptions
4. Recommendations and Insights
from AMI’s Perspective**
5.
Holistic Overview
of EEG Devices for Sleep and Sleep
Architecture Market
6. Market Synopsis: EEG Devices for Sleep and Sleep Architecture Market
7.
EEG Devices for Sleep and Sleep Architecture Market
Analysis: Qualitative Perspective
7.1. Introduction
7.1.1. Product Definition
7.1.2.
Industry Development
7.2.
Market Dynamics
7.2.1.
Drivers
7.2.2. Restraints
7.2.3.
Opportunities
7.3. Trends in EEG Devices
for Sleep and Sleep Architecture Market
7.4.
Market Determinants Radar Chart
7.5.
Macro-Economic and Micro-Economic Indicators: EEG Devices
for Sleep and Sleep
Architecture Market
7.6. Porter’s Five Force Analysis
7.7. Impact of Covid-19 on EEG Devices
for Sleep and Sleep Architecture Market
8.
Global EEG Devices
for Sleep and Sleep
Architecture Market Analysis and Forecasts, 2022 –2030
8.1. Overview
8.1.1.
Global EEG Devices
for Sleep and Sleep Architecture Market Revenue (US$ Mn)
8.2.
Global EEG Devices
for Sleep and Sleep Architecture Market Revenue (US$ Mn) and Forecasts, By Channels
8.2.1. 1 Channel
8.2.1.1.
Definition
8.2.1.2.
Market Estimation and Penetration, 2015 – 2021
8.2.1.3.
Market Forecast, 2022 – 2030
8.2.1.4.
Compound Annual Growth
Rate (CAGR)
8.2.1.5.
Regional Bifurcation
8.2.1.5.1.
North America
8.2.1.5.1.1.
Market Estimation, 2015 – 2021
8.2.1.5.1.2.
Market Forecast, 2022 – 2030
8.2.1.5.2.
Europe
8.2.1.5.2.1.
Market Estimation, 2015 – 2021
8.2.1.5.2.2.
Market Forecast, 2022 – 2030
8.2.1.5.3.
Asia Pacific
8.2.1.5.3.1.
Market Estimation, 2015 – 2021
8.2.1.5.3.2.
Market Forecast, 2022 – 2030
8.2.1.5.4.
Middle East and Africa
8.2.1.5.4.1.
Market Estimation, 2015 – 2021
8.2.1.5.4.2.
Market Forecast, 2022 – 2030
8.2.1.5.5.
Latin America
8.2.1.5.5.1.
Market Estimation, 2015 – 2021
8.2.1.5.5.2.
Market Forecast, 2022 – 2030
8.2.2.
4 Channels
8.2.2.1.
Definition
8.2.2.2.
Market Estimation and Penetration, 2015 – 2021
8.2.2.3.
Market Forecast, 2022 – 2030
8.2.2.4.
Compound Annual Growth
Rate (CAGR)
8.2.2.5.
Regional Bifurcation
8.2.2.5.1.
North America
8.2.2.5.1.1.
Market Estimation, 2015 – 2021
8.2.2.5.1.2.
Market Forecast, 2022 – 2030
8.2.2.5.2.
Europe
8.2.2.5.2.1.
Market Estimation, 2015 – 2021
8.2.2.5.2.2.
Market Forecast, 2022 – 2030
8.2.2.5.3.
Asia Pacific
8.2.2.5.3.1.
Market Estimation, 2015 – 2021
8.2.2.5.3.2.
Market Forecast, 2022 – 2030
8.2.2.5.4.
Middle East and Africa
8.2.2.5.4.1.
Market Estimation, 2015 – 2021
8.2.2.5.4.2.
Market Forecast, 2022 – 2030
8.2.2.5.5.
Latin America
8.2.2.5.5.1.
Market Estimation, 2015 – 2021
8.2.2.5.5.2.
Market Forecast, 2022 – 2030
8.2.3.
pay-per-use + 5 or 14 channels
8.2.3.1.
Definition
8.2.3.2.
Market Estimation and Penetration, 2015 – 2021
8.2.3.3.
Market Forecast, 2022 – 2030
8.2.3.4.
Compound Annual Growth
Rate (CAGR)
8.2.3.5.
Regional Bifurcation
8.2.3.5.1.
North America
8.2.3.5.1.1.
Market Estimation, 2015 – 2021
8.2.3.5.1.2.
Market Forecast, 2022 – 2030
8.2.3.5.2.
Europe
8.2.3.5.2.1.
Market Estimation, 2015 – 2021
8.2.3.5.2.2.
Market Forecast, 2022 – 2030
8.2.3.5.3.
Asia Pacific
8.2.3.5.3.1.
Market Estimation, 2015 – 2021
8.2.3.5.3.2.
Market Forecast, 2022 – 2030
8.2.3.5.4.
Middle East and Africa
8.2.3.5.4.1.
Market Estimation, 2015 – 2021
8.2.3.5.4.2.
Market Forecast, 2022 – 2030
8.2.3.5.5.
Latin America
8.2.3.5.5.1.
Market Estimation, 2015 – 2021
8.2.3.5.5.2.
Market Forecast, 2022 – 2030
8.2.4.
8 -16 Channels
8.2.4.1.
Definition
8.2.4.2.
Market Estimation and Penetration, 2015 – 2021
8.2.4.3.
Market Forecast, 2022 – 2030
8.2.4.4.
Compound Annual Growth
Rate (CAGR)
8.2.4.5.
Regional Bifurcation
8.2.4.5.1.
North America
8.2.4.5.1.1.
Market Estimation, 2015 – 2021
8.2.4.5.1.2.
Market Forecast, 2022 – 2030
8.2.4.5.2.
Europe
8.2.4.5.2.1.
Market Estimation, 2015 – 2021
8.2.4.5.2.2.
Market Forecast, 2022 – 2030
8.2.4.5.3.
Asia Pacific
8.2.4.5.3.1.
Market Estimation, 2015 – 2021
8.2.4.5.3.2.
Market Forecast, 2022 – 2030
8.2.4.5.4.
Middle East and Africa
8.2.4.5.4.1.
Market Estimation, 2015 – 2021
8.2.4.5.4.2.
Market Forecast, 2022 – 2030
8.2.4.5.5.
Latin America
8.2.4.5.5.1.
Market Estimation, 2015 – 2021
8.2.4.5.5.2.
Market Forecast, 2022 – 2030
8.2.5. Above 16 Channels
8.2.5.1.
Definition
8.2.5.2.
Market Estimation and Penetration, 2015 – 2021
8.2.5.3.
Market Forecast, 2022 – 2030
8.2.5.4.
Compound Annual Growth
Rate (CAGR)
8.2.5.5.
Regional Bifurcation
8.2.5.5.1.
North America
8.2.5.5.1.1.
Market Estimation, 2015 – 2021
8.2.5.5.1.2.
Market Forecast, 2022 – 2030
8.2.5.5.2.
Europe
8.2.5.5.2.1.
Market Estimation, 2015 – 2021
8.2.5.5.2.2.
Market Forecast, 2022 – 2030
8.2.5.5.3.
Asia Pacific
8.2.5.5.3.1.
Market Estimation, 2015 – 2021
8.2.5.5.3.2.
Market Forecast, 2022 – 2030
8.2.5.5.4.
Middle East and Africa
8.2.5.5.4.1.
Market Estimation, 2015 – 2021
8.2.5.5.4.2.
Market Forecast, 2022 – 2030
8.2.5.5.5.
Latin America
8.2.5.5.5.1.
Market Estimation, 2015 – 2021
8.2.5.5.5.2.
Market Forecast, 2022 – 2030
8.3. Key Segment
for Channeling Investments
8.3.1. By Channels
9.
Global EEG Devices
for Sleep and Sleep
Architecture Market Analysis and Forecasts, 2022 – 2030
9.1. Overview
9.2.
Global EEG Devices
for Sleep and Sleep Architecture Market Revenue (US$ Mn) and Forecasts, By Offering
9.2.1.
Products (Definition, Market Estimation and
Penetration, 2015 – 2021, Market Estimation (2015 – 2021), Market Forecast (2022
– 2030), Compound Annual Growth Rate (CAGR), Regional Bifurcation (North
America, Europe, Asia Pacific, Middle East and Africa, Latin America) and Information on Partially or fully Flexible Systems, Headcaps/Headsets, Fixed
Units, Others)
9.2.1.1.
Partially or fully Flexible Systems
9.2.1.2.
Headcaps/Headsets
9.2.1.3.
Fixed Units
9.2.1.4.
Others
9.2.2.
Solution and Services
9.2.2.1.
Definition
9.2.2.2.
Market Estimation and Penetration, 2015 – 2021
9.2.2.3.
Market Forecast, 2022 – 2030
9.2.2.4.
Compound Annual Growth
Rate (CAGR)
9.2.2.5.
Regional Bifurcation
9.2.2.5.1.
North America
9.2.2.5.1.1.
Market Estimation, 2015 – 2021
9.2.2.5.1.2.
Market Forecast, 2022 – 2030
9.2.2.5.2.
Europe
9.2.2.5.2.1.
Market Estimation, 2015 – 2021
9.2.2.5.2.2.
Market Forecast, 2022 – 2030
9.2.2.5.3.
Asia Pacific
9.2.2.5.3.1.
Market Estimation, 2015 – 2021
9.2.2.5.3.2.
Market Forecast, 2022 – 2030
9.2.2.5.4.
Middle East and Africa
9.2.2.5.4.1.
Market Estimation, 2015 – 2021
9.2.2.5.4.2.
Market Forecast, 2022 – 2030
9.2.2.5.5.
Latin America
9.2.2.5.5.1.
Market Estimation, 2015 – 2021
9.2.2.5.5.2.
Market Forecast, 2022 – 2030
9.3. Key Segment
for Channeling Investments
9.3.1. By Offering
10.
Global EEG Devices
for Sleep and Sleep
Architecture Market Analysis and Forecasts, 2022 – 2030
10.1.
Overview
10.2.
Global EEG Devices for Sleep and Sleep Architecture
Market Revenue (US$ Mn) and Forecasts, By End Use
10.2.1. Research and Universities
10.2.1.1.
Definition
10.2.1.2.
Market Estimation and Penetration, 2015 – 2021
10.2.1.3.
Market Forecast, 2022 – 2030
10.2.1.4.
Compound Annual Growth Rate (CAGR)
10.2.1.5.
Regional Bifurcation
10.2.1.5.1.
North America
10.2.1.5.1.1.
Market Estimation, 2015 – 2021
10.2.1.5.1.2.
Market Forecast, 2022 – 2030
10.2.1.5.2.
Europe
10.2.1.5.2.1.
Market Estimation, 2015 – 2021
10.2.1.5.2.2.
Market Forecast, 2022 – 2030
10.2.1.5.3.
Asia Pacific
10.2.1.5.3.1.
Market Estimation, 2015 – 2021
10.2.1.5.3.2.
Market Forecast, 2022 – 2030 10.2.1.5.4. Middle East and
Africa
10.2.1.5.4.1.
Market Estimation, 2015 – 2021
10.2.1.5.4.2.
Market Forecast, 2022 – 2030
10.2.1.5.5.
Latin America
10.2.1.5.5.1.
Market Estimation, 2015 – 2021
10.2.1.5.5.2.
Market Forecast, 2022 – 2030
10.2.2.
In-Home
10.2.2.1.
Definition
10.2.2.2.
Market Estimation and Penetration, 2015 – 2021
10.2.2.3.
Market Forecast, 2022 – 2030
10.2.2.4.
Compound Annual Growth
Rate (CAGR)
10.2.2.5.
Regional Bifurcation
10.2.2.5.1.
North America
10.2.2.5.1.1.
Market Estimation, 2015 – 2021
10.2.2.5.1.2.
Market Forecast, 2022 – 2030
10.2.2.5.2.
Europe
10.2.2.5.2.1.
Market Estimation, 2015 – 2021
10.2.2.5.2.2.
Market Forecast, 2022 – 2030
10.2.2.5.3.
Asia Pacific
10.2.2.5.3.1.
Market Estimation, 2015 – 2021
10.2.2.5.3.2.
Market Forecast, 2022 – 2030 10.2.2.5.4. Middle East and
Africa
10.2.2.5.4.1.
Market Estimation, 2015 – 2021
10.2.2.5.4.2.
Market Forecast, 2022 – 2030
10.2.2.5.5. Latin
America
10.2.3. Hospital/Clinics
10.2.3.1.
Definition
10.2.2.5.5.1.
Market Estimation, 2015 – 2021
10.2.2.5.5.2.
Market Forecast, 2022 – 2030
10.2.3.2.
Market Estimation and Penetration, 2015 – 2021
10.2.3.3.
Market Forecast, 2022 – 2030
10.2.3.4.
Compound Annual Growth
Rate (CAGR)
10.2.3.5.
Regional Bifurcation
10.2.3.5.1.
North America
10.2.3.5.1.1.
Market Estimation, 2015 – 2021
10.2.3.5.1.2.
Market Forecast, 2022 – 2030
10.2.3.5.2.
Europe
10.2.3.5.2.1.
Market Estimation, 2015 – 2021
10.2.3.5.2.2.
Market Forecast, 2022 – 2030
10.2.3.5.3.
Asia Pacific
10.2.3.5.3.1.
Market Estimation, 2015 – 2021
10.2.3.5.3.2.
Market Forecast, 2022 – 2030 10.2.3.5.4. Middle East and
Africa
10.2.3.5.4.1.
Market Estimation, 2015 – 2021
10.2.3.5.4.2.
Market Forecast, 2022 – 2030
10.2.3.5.5.
Latin America
10.2.3.5.5.1.
Market Estimation, 2015 – 2021
10.2.3.5.5.2.
Market Forecast, 2022 – 2030
10.2.4.
Businesses (Employers)
10.2.4.1.
Definition
10.2.4.2.
Market Estimation and Penetration, 2015 – 2021
10.2.4.3.
Market Forecast, 2022 – 2030
10.2.4.4.
Compound Annual Growth
Rate (CAGR)
10.2.4.5.
Regional Bifurcation
10.2.4.5.1.
North America
10.2.4.5.1.1.
Market Estimation, 2015 – 2021
10.2.4.5.1.2.
Market Forecast, 2022 – 2030
10.2.4.5.2.
Europe
10.2.4.5.2.1.
Market Estimation, 2015 – 2021
10.2.4.5.2.2.
Market Forecast, 2022 – 2030
10.2.4.5.3.
Asia Pacific
10.2.4.5.3.1.
Market Estimation, 2015 – 2021
10.2.4.5.3.2.
Market Forecast, 2022 – 2030 10.2.4.5.4. Middle East and
Africa
10.2.4.5.4.1.
Market Estimation, 2015 – 2021
10.2.4.5.4.2.
Market Forecast, 2022 – 2030
10.2.4.5.5.
Latin America
10.2.4.5.5.1.
Market Estimation, 2015 – 2021
10.2.4.5.5.2.
Market Forecast, 2022 – 2030
10.2.5.
Others
10.2.5.1.
Definition
10.2.5.2.
Market Estimation and Penetration, 2015 – 2021
10.2.5.3.
Market Forecast, 2022 – 2030
10.2.5.4.
Compound Annual Growth
Rate (CAGR)
10.2.5.5.
Regional Bifurcation
10.2.5.5.1.
North America
10.2.5.5.1.1.
Market Estimation, 2015 – 2021
10.2.5.5.1.2.
Market Forecast, 2022 – 2030
10.2.5.5.2.
Europe
10.2.5.5.2.1.
Market Estimation, 2015 – 2021
10.2.5.5.2.2.
Market Forecast, 2022 – 2030
10.2.5.5.3.
Asia Pacific
10.2.5.5.3.1.
Market Estimation, 2015 – 2021
10.2.5.5.3.2.
Market Forecast, 2022 – 2030 10.2.5.5.4. Middle East and
Africa
10.2.5.5.4.1.
Market Estimation, 2015 – 2021
10.2.5.5.4.2.
Market Forecast, 2022 – 2030
10.2.5.5.5.
Latin America
10.2.5.5.5.1.
Market Estimation, 2015 – 2021
10.2.5.5.5.2.
Market Forecast, 2022 – 2030
10.3. Key Segment
for Channeling Investments
10.3.1. By End Use
11.
Global EEG Devices
for Sleep and Sleep
Architecture Market Analysis and Forecasts, 2022 – 2030
11.1.
Overview
11.2.
Global EEG Devices for Sleep and Sleep Architecture
Market Revenue (US$ Mn) and
Forecasts, By Application
11.2.1.
Clinical (Definition, Market Estimation and
Penetration, 2015 – 2021, Market Estimation (2015 – 2021), Market Forecast (2022
– 2030), Compound Annual Growth Rate (CAGR), Regional Bifurcation (North
America, Europe, Asia Pacific, Middle East and Africa, Latin America) and Information on Insomnia, Hypersomnia, Other non-OSA sleep disorders)
11.2.1.1.
Insomnia
11.2.1.2.
Hypersomnia
11.2.1.3.
Other non-OSA sleep disorders
11.2.2.
Research (Definition, Market Estimation and
Penetration, 2015 – 2021, Market Estimation (2015 – 2021), Market Forecast (2022
– 2030), Compound Annual Growth Rate (CAGR), Regional Bifurcation (North
America, Europe, Asia Pacific, Middle East and Africa, Latin America) and Information on REM sleep without Atonia in patients with RBD, Prodromal
sleep biomarkers for neurodegenerative disease, Effect of Suvorexant
progressive supranuclear palsy, Sleep patterns in patients with ICU delirium,
Sleep quality changes as a result of cannabis and opioid dependency, Outcomes
resulting from an insomnia intervention, Influence of sleep deprivation on
memory, Others)
11.2.2.1.
REM sleep without
Atonia in patients
with RBD
11.2.2.2.
Prodromal sleep biomarkers for neurodegenerative disease
11.2.2.3.
Effect of Suvorexant progressive supranuclear palsy
11.2.2.4.
Sleep patterns in patients with ICU delirium
11.2.2.5.
Sleep quality changes
as a result of cannabis
and opioid dependency
11.2.2.6.
Outcomes resulting from an insomnia
intervention
11.2.2.7.
Influence of sleep
deprivation on memory
11.2.2.8.
Others
11.2.3.
Positional Sleep Apnea Therapy
11.2.3.1.
Definition
11.2.3.2.
Market Estimation and Penetration, 2015 – 2021
11.2.3.3.
Market Forecast, 2022 – 2030
11.2.3.4.
Compound Annual Growth
Rate (CAGR)
11.2.3.5.
Regional Bifurcation
11.2.3.5.1.
North America
11.2.3.5.1.1.
Market Estimation, 2015 – 2021
11.2.3.5.1.2.
Market Forecast, 2022 – 2030
11.2.3.5.2.
Europe
11.2.3.5.2.1.
Market Estimation, 2015 – 2021
11.2.3.5.2.2.
Market Forecast, 2022 – 2030
11.2.3.5.3.
Asia Pacific
11.2.3.5.3.1.
Market Estimation, 2015 – 2021
11.2.3.5.3.2.
Market Forecast, 2022 – 2030 11.2.3.5.4. Middle East and Africa
11.2.3.5.4.1.
Market Estimation, 2015 – 2021
11.2.3.5.4.2.
Market Forecast, 2022 – 2030
11.2.3.5.5.
Latin America
11.2.3.5.5.1.
Market Estimation, 2015 – 2021
11.2.3.5.5.2.
Market Forecast, 2022 – 2030
11.2.4. Assess Sleep Architecture and Continuity
11.2.4.1.
Definition
11.2.4.2.
Market Estimation and Penetration, 2015 – 2021
11.2.4.3.
Market Forecast, 2022 – 2030
11.2.4.4.
Compound Annual Growth
Rate (CAGR)
11.2.4.5.
Regional Bifurcation
11.2.4.5.1.
North America
11.2.4.5.1.1.
Market Estimation, 2015 – 2021
11.2.4.5.1.2.
Market Forecast, 2022 – 2030
11.2.4.5.2.
Europe
11.2.4.5.2.1.
Market Estimation, 2015 – 2021
11.2.4.5.2.2.
Market Forecast, 2022 – 2030
11.2.4.5.3.
Asia Pacific
11.2.4.5.3.1.
Market Estimation, 2015 – 2021
11.2.4.5.3.2.
Market Forecast, 2022 – 2030 11.2.4.5.4. Middle East and
Africa
11.2.4.5.4.1.
Market Estimation, 2015 – 2021
11.2.4.5.4.2.
Market Forecast, 2022 – 2030
11.2.4.5.5.
Latin America
11.2.4.5.5.1.
Market Estimation, 2015 – 2021
11.2.4.5.5.2.
Market Forecast, 2022 – 2030
11.2.5. Others
11.2.5.1.
Definition
11.2.5.2.
Market Estimation and Penetration, 2015 – 2021
11.2.5.3.
Market Forecast, 2022 – 2030
11.2.5.4.
Compound Annual Growth
Rate (CAGR)
11.2.5.5.
Regional Bifurcation
11.2.5.5.1.
North America
11.2.5.5.1.1.
Market Estimation, 2015 – 2021
11.2.5.5.1.2.
Market Forecast, 2022 – 2030
11.2.5.5.2.
Europe
11.2.5.5.2.1.
Market Estimation, 2015 – 2021
11.2.5.5.2.2.
Market Forecast, 2022 – 2030
11.2.5.5.3.
Asia Pacific
11.2.5.5.3.1.
Market Estimation, 2015 – 2021
11.2.5.5.3.2.
Market Forecast, 2022 – 2030 11.2.5.5.4. Middle East and
Africa
11.2.5.5.4.1.
Market Estimation, 2015 – 2021
11.2.5.5.4.2.
Market Forecast, 2022 – 2030
11.2.5.5.5.
Latin America
11.2.5.5.5.1.
Market Estimation, 2015 – 2021
11.2.5.5.5.2.
Market Forecast, 2022 – 2030
11.3. Key Segment
for Channeling Investments
11.3.1. By Application
12.
North America
EEG Devices for Sleep and Sleep
Architecture Market Analysis and Forecasts, 2022 – 2030
12.1.
Overview
12.1.1.
North America EEG
Devices for Sleep and Sleep Architecture Market Revenue (US$ Mn)
12.2.
North America EEG
Devices for Sleep and Sleep Architecture Market Revenue (US$
Mn) and Forecasts, By Channels
12.2.1. 1 Channel
12.2.2. 4 Channels
12.2.3.
pay-per-use + 5 or 14 channels
12.2.4. 8 -16 Channels
12.2.5.
Above 16 Channels
12.3.
North America EEG
Devices for Sleep and Sleep Architecture Market Revenue (US$
Mn) and Forecasts, By Offering
12.3.1. Products
12.3.1.1.
Partially or fully Flexible Systems
12.3.1.2.
Headcaps/Headsets
12.3.1.3.
Fixed Units
12.3.1.4.
Others
12.3.2.
Solution and Services
12.4.
North America EEG
Devices for Sleep and Sleep Architecture Market Revenue (US$ Mn) and Forecasts, By End Use
12.4.1. Research and Universities
12.4.2. In-Home
12.4.3.
Hospital/Clinics
12.4.4.
Businesses (Employers)
12.4.5.
Others
12.5.
North America EEG
Devices for Sleep and Sleep Architecture Market Revenue (US$
Mn) and Forecasts, By Application
12.5.1. Clinical
12.5.1.1.
Insomnia
12.5.1.2.
Hypersomnia
12.5.1.3.
Other non-OSA sleep disorders
12.5.2. Research
12.5.2.1.
REM sleep without
Atonia in patients
with RBD
12.5.2.2.
Prodromal sleep biomarkers for neurodegenerative disease
12.5.2.3.
Effect of Suvorexant progressive supranuclear palsy
12.5.2.4.
Sleep patterns in patients with ICU delirium
12.5.2.5.
Sleep quality changes
as a result of cannabis
and opioid dependency
12.5.2.6.
Outcomes resulting from an insomnia
intervention
12.5.2.7.
Influence of sleep
deprivation on memory
12.5.2.8.
Others
12.5.3.
Positional Sleep Apnea Therapy
12.5.4. Assess Sleep Architecture and Continuity
12.5.5.
Others
12.6.
North America EEG
Devices for Sleep and Sleep Architecture Market Revenue (US$
Mn) and Forecasts, By Country
12.6.1. U.S
12.6.1.1.
U.S EEG Devices
for Sleep and Sleep Architecture Market Revenue (US$ Mn) and Forecasts, By Channels
12.6.1.1.1.
1 Channel
12.6.1.1.2.
4 Channels
12.6.1.1.3.
pay-per-use + 5 or 14 channels
12.6.1.1.4.
8 -16 Channels
12.6.1.1.5.
Above 16 Channels
12.6.1.2.
U.S EEG Devices
for Sleep and Sleep Architecture Market Revenue (US$ Mn) and Forecasts, By Offering
12.6.1.2.1.
Products
12.6.1.2.1.1.
Partially or fully Flexible Systems 12.6.1.2.1.2. Headcaps/Headsets
12.6.1.2.1.3.
Fixed Units
12.6.1.2.1.4.
Others
12.6.1.2.2.
Solution and Services
12.6.1.3.
U.S EEG Devices
for Sleep and Sleep Architecture Market Revenue (US$ Mn) and Forecasts, By End Use
12.6.1.3.1.
Research and Universities 12.6.1.3.2. In-Home
12.6.1.3.3.
Hospital/Clinics
12.6.1.3.4.
Businesses (Employers)
12.6.1.3.5.
Others
12.6.1.4.
U.S EEG Devices
for Sleep and Sleep Architecture Market Revenue (US$ Mn) and Forecasts, By Application
12.6.1.4.1.
Clinical
12.6.1.4.1.1.
Insomnia
12.6.1.4.1.2.
Hypersomnia
12.6.1.4.1.3.
Other non-OSA sleep disorders
12.6.1.4.2. Research
12.6.2. Canada
12.6.1.4.2.1.
REM sleep without
Atonia in patients
with RBD
12.6.1.4.2.2.
Prodromal sleep biomarkers for neurodegenerative
disease
12.6.1.4.2.3.
Effect of Suvorexant progressive supranuclear
palsy
12.6.1.4.2.4.
Sleep patterns in patients with ICU delirium 12.6.1.4.2.5. Sleep
quality changes as a result of cannabis
and
opioid dependency
12.6.1.4.2.6. Outcomes
resulting from an insomnia intervention 12.6.1.4.2.7. Influence of
sleep deprivation on memory 12.6.1.4.2.8. Others
12.6.1.4.3.
Positional Sleep Apnea Therapy 12.6.1.4.4. Assess Sleep
Architecture and Continuity 12.6.1.4.5. Others
12.6.2.1.
Canada EEG Devices
for Sleep and Sleep Architecture Market Revenue (US$
Mn) and Forecasts, By Channels
12.6.2.1.1.
1 Channel
12.6.2.1.2.
4 Channels
12.6.2.1.3.
pay-per-use + 5 or 14 channels
12.6.2.1.4.
8 -16 Channels
12.6.2.1.5.
Above 16 Channels
12.6.2.2.
Canada EEG Devices
for Sleep and Sleep Architecture Market Revenue (US$
Mn) and Forecasts, By Offering
12.6.2.2.1.
Products
12.6.2.2.1.1.
Partially or fully Flexible Systems 12.6.2.2.1.2. Headcaps/Headsets
12.6.2.2.1.3.
Fixed Units
12.6.2.2.1.4.
Others
12.6.2.2.2.
Solution and Services
12.6.2.3.
Canada EEG Devices
for Sleep and Sleep Architecture Market Revenue (US$
Mn) and Forecasts, By End Use
12.6.2.3.1.
Research and Universities 12.6.2.3.2. In-Home
12.6.2.3.3.
Hospital/Clinics
12.6.2.3.4.
Businesses (Employers)
12.6.2.3.5.
Others
12.6.2.4.
Canada EEG Devices
for Sleep and Sleep Architecture Market Revenue (US$
Mn) and Forecasts, By Application
12.6.2.4.1.
Clinical
12.6.3. Mexico
12.6.2.4.1.1.
Insomnia
12.6.2.4.1.2.
Hypersomnia
12.6.2.4.1.3.
Other non-OSA sleep disorders
12.6.2.4.2. Research
12.6.2.4.2.1.
REM sleep without
Atonia in patients
with RBD
12.6.2.4.2.2.
Prodromal sleep biomarkers for neurodegenerative
disease
12.6.2.4.2.3.
Effect of Suvorexant progressive supranuclear
palsy
12.6.2.4.2.4.
Sleep patterns in patients with ICU delirium 12.6.2.4.2.5. Sleep
quality changes as a result of cannabis
and
opioid dependency
12.6.2.4.2.6. Outcomes
resulting from an insomnia intervention 12.6.2.4.2.7. Influence of
sleep deprivation on memory 12.6.2.4.2.8. Others
12.6.2.4.3.
Positional Sleep Apnea Therapy 12.6.2.4.4. Assess Sleep
Architecture and Continuity 12.6.2.4.5. Others
12.6.3.1.
Mexico EEG Devices
for Sleep and Sleep Architecture Market Revenue (US$ Mn) and Forecasts, By Channels
12.6.3.1.1.
1 Channel
12.6.3.1.2.
4 Channels
12.6.3.1.3.
pay-per-use + 5 or 14 channels
12.6.3.1.4.
8 -16 Channels
12.6.3.1.5.
Above 16 Channels
12.6.3.2.
Mexico EEG Devices
for Sleep and Sleep Architecture Market Revenue (US$
Mn) and Forecasts, By Offering
12.6.3.2.1.
Products
12.6.3.2.1.1.
Partially or fully Flexible Systems 12.6.3.2.1.2. Headcaps/Headsets
12.6.3.2.1.3.
Fixed Units
12.6.3.2.1.4.
Others
12.6.3.2.2.
Solution and Services
12.6.3.3.
Mexico EEG Devices
for Sleep and Sleep Architecture Market Revenue (US$
Mn) and Forecasts, By End Use
12.6.3.3.1.
Research and Universities 12.6.3.3.2. In-Home
12.6.3.3.3.
Hospital/Clinics
12.6.3.3.4.
Businesses (Employers)
12.6.3.3.5.
Others
12.6.3.4.
Mexico EEG Devices
for Sleep and Sleep Architecture Market Revenue (US$
Mn) and Forecasts, By Application
12.6.3.4.1.
Clinical
12.6.3.4.1.1.
Insomnia
12.6.3.4.1.2.
Hypersomnia
12.6.3.4.1.3.
Other non-OSA sleep disorders
12.6.3.4.2. Research
12.6.3.4.2.1.
REM sleep without
Atonia in patients
with RBD
12.6.3.4.2.2.
Prodromal sleep biomarkers for neurodegenerative
disease
12.6.3.4.2.3.
Effect of Suvorexant progressive supranuclear
palsy
12.6.3.4.2.4.
Sleep patterns in patients with ICU delirium 12.6.3.4.2.5. Sleep
quality changes as a result of cannabis
and
opioid dependency
12.6.3.4.2.6. Outcomes
resulting from an insomnia intervention 12.6.3.4.2.7. Influence of
sleep deprivation on memory 12.6.3.4.2.8. Others
12.6.3.4.3.
Positional Sleep Apnea Therapy 12.6.3.4.4. Assess Sleep
Architecture and Continuity 12.6.3.4.5. Others
12.6.4. Rest of North America
12.6.4.1.
Rest of North
America EEG Devices
for Sleep and Sleep Architecture Market Revenue (US$ Mn) and
Forecasts, By Channels
12.6.4.1.1.
1 Channel
12.6.4.1.2.
4 Channels
12.6.4.1.3.
pay-per-use + 5 or 14 channels
12.6.4.1.4.
8 -16 Channels
12.6.4.1.5.
Above 16 Channels
12.6.4.2.
Rest of North
America EEG Devices
for Sleep and Sleep Architecture Market Revenue (US$ Mn) and
Forecasts, By Offering
12.6.4.2.1.
Products
12.6.4.2.1.1.
Partially or fully Flexible Systems 12.6.4.2.1.2. Headcaps/Headsets
12.6.4.2.1.3.
Fixed Units
12.6.4.2.1.4.
Others
12.6.4.2.2.
Solution and Services
12.6.4.3.
Rest of North
America EEG Devices
for Sleep and Sleep Architecture Market Revenue (US$ Mn) and
Forecasts, By End Use
12.6.4.3.1.
Research and Universities 12.6.4.3.2. In-Home
12.6.4.3.3.
Hospital/Clinics
12.6.4.3.4.
Businesses (Employers)
12.6.4.3.5.
Others
12.6.4.4.
Rest of North America EEG Devices for Sleep and Sleep Architecture Market Revenue (US$ Mn) and
Forecasts, By Application
12.6.4.4.1.
Clinical
12.6.4.4.1.1.
Insomnia
12.6.4.4.1.2.
Hypersomnia
12.6.4.4.1.3.
Other non-OSA sleep disorders
12.6.4.4.2. Research
12.6.4.4.2.1.
REM sleep without
Atonia in patients
with RBD
12.6.4.4.2.2.
Prodromal sleep biomarkers for neurodegenerative
disease
12.6.4.4.2.3.
Effect of Suvorexant progressive supranuclear
palsy
12.6.4.4.2.4.
Sleep patterns in patients with ICU delirium 12.6.4.4.2.5. Sleep
quality changes as a result of cannabis
and
opioid dependency
12.6.4.4.2.6. Outcomes
resulting from an insomnia intervention 12.6.4.4.2.7. Influence of
sleep deprivation on memory 12.6.4.4.2.8. Others
12.6.4.4.3.
Positional Sleep Apnea Therapy 12.6.4.4.4. Assess Sleep
Architecture and Continuity 12.6.4.4.5. Others
12.7.
Key Segment for Channeling Investments
12.7.1. By Country
12.7.2.
By Channels
12.7.3.
By Offering
12.7.4.
By End Use
12.7.5.
By Application
13.
Europe EEG Devices
for Sleep and Sleep
Architecture Market Analysis
and Forecasts, 2020
- 2028
13.1.
Overview
13.1.1.
Europe EEG Devices
for Sleep and Sleep Architecture Market Revenue (US$ Mn)
13.2.
Europe EEG
Devices for Sleep and Sleep Architecture Market Revenue
(US$ Mn) and Forecasts, By Channels
13.2.1. 1 Channel
13.2.2.
4 Channels
13.2.3. pay-per-use + 5 or 14 channels
13.2.4.
8 -16 Channels
13.2.5. Above 16 Channels
13.3.
Europe EEG
Devices for Sleep and Sleep Architecture Market Revenue
(US$ Mn) and Forecasts, By Offering
13.3.1. Products
13.3.1.1.
Partially or fully Flexible Systems
13.3.1.2.
Headcaps/Headsets
13.3.1.3.
Fixed Units
13.3.1.4.
Others
13.3.2.
Solution and Services
13.4.
Europe EEG
Devices for Sleep and Sleep Architecture Market Revenue
(US$ Mn) and Forecasts, By End Use
13.4.1. Research and Universities
13.4.2.
In-Home
13.4.3. Hospital/Clinics
13.4.4.
Businesses (Employers)
13.4.5.
Others
13.5.
Europe EEG
Devices for Sleep and Sleep Architecture Market Revenue
(US$ Mn) and Forecasts, By Application
13.5.1. Clinical
13.5.1.1.
Insomnia
13.5.1.2.
Hypersomnia
13.5.1.3.
Other non-OSA sleep disorders
13.5.2.
Research
13.5.2.1.
REM sleep without
Atonia in patients
with RBD
13.5.2.2.
Prodromal sleep biomarkers for neurodegenerative disease
13.5.2.3.
Effect of Suvorexant progressive supranuclear palsy
13.5.2.4.
Sleep patterns in patients with ICU delirium
13.5.2.5.
Sleep quality changes
as a result of cannabis
and opioid dependency
13.5.2.6.
Outcomes resulting from an insomnia
intervention
13.5.2.7.
Influence of sleep
deprivation on memory
13.5.2.8.
Others
13.5.3. Positional Sleep
Apnea Therapy
13.5.4.
Assess Sleep Architecture and Continuity
13.5.5.
Others
13.6.
Europe EEG
Devices for Sleep and Sleep Architecture Market Revenue
(US$ Mn) and Forecasts, By Country
13.6.1. France
13.6.1.1.
France EEG Devices
for Sleep and Sleep Architecture Market Revenue (US$
Mn) and Forecasts, By Channels
13.6.1.1.1.
1 Channel
13.6.1.1.2.
4 Channels
13.6.1.1.3.
pay-per-use + 5 or 14 channels
13.6.1.1.4.
8 -16 Channels
13.6.1.1.5.
Above 16 Channels
13.6.1.2.
France EEG Devices
for Sleep and Sleep Architecture Market Revenue (US$
Mn) and Forecasts, By Offering
13.6.1.2.1.
Products
13.6.1.2.1.1.
Partially or fully Flexible Systems 13.6.1.2.1.2. Headcaps/Headsets
13.6.1.2.1.3.
Fixed Units
13.6.1.2.1.4.
Others
13.6.1.2.2.
Solution and Services
13.6.1.3.
France EEG Devices
for Sleep and Sleep Architecture Market Revenue (US$
Mn) and Forecasts, By End Use
13.6.1.3.1.
Research and Universities 13.6.1.3.2. In-Home
13.6.1.3.3.
Hospital/Clinics
13.6.1.3.4.
Businesses (Employers)
13.6.1.3.5.
Others
13.6.1.4.
France EEG Devices
for Sleep and Sleep Architecture Market Revenue (US$
Mn) and Forecasts, By Application
13.6.1.4.1.
Clinical
13.6.1.4.1.1.
Insomnia
13.6.1.4.1.2.
Hypersomnia
13.6.1.4.1.3.
Other non-OSA sleep disorders
13.6.1.4.2. Research
13.6.1.4.2.1.
REM sleep without
Atonia in patients
with RBD
13.6.1.4.2.2.
Prodromal sleep biomarkers for neurodegenerative
disease
13.6.1.4.2.3.
Effect of Suvorexant progressive supranuclear
palsy
13.6.1.4.2.4.
Sleep patterns in patients with ICU delirium 13.6.1.4.2.5. Sleep
quality changes as a result of cannabis
and
opioid dependency
13.6.1.4.2.6. Outcomes
resulting from an insomnia intervention 13.6.1.4.2.7. Influence of
sleep deprivation on memory 13.6.1.4.2.8. Others
13.6.2. The UK
13.6.1.4.3.
Positional Sleep Apnea Therapy 13.6.1.4.4. Assess Sleep
Architecture and Continuity 13.6.1.4.5. Others
13.6.2.1.
The UK EEG Devices for Sleep and Sleep Architecture Market Revenue (US$
Mn) and Forecasts, By Channels
13.6.2.1.1.
1 Channel
13.6.2.1.2.
4 Channels
13.6.2.1.3.
pay-per-use + 5 or 14 channels
13.6.2.1.4.
8 -16 Channels
13.6.2.1.5.
Above 16 Channels
13.6.2.2.
The UK EEG Devices for Sleep and Sleep Architecture Market Revenue (US$
Mn) and Forecasts, By Offering
13.6.2.2.1.
Products
13.6.2.2.1.1.
Partially or fully Flexible Systems 13.6.2.2.1.2. Headcaps/Headsets
13.6.2.2.1.3.
Fixed Units
13.6.2.2.1.4.
Others
13.6.2.2.2.
Solution and Services
13.6.2.3.
The UK EEG Devices for Sleep and Sleep Architecture Market Revenue (US$
Mn) and Forecasts, By End Use
13.6.2.3.1.
Research and Universities 13.6.2.3.2. In-Home
13.6.2.3.3.
Hospital/Clinics
13.6.2.3.4.
Businesses (Employers)
13.6.2.3.5.
Others
13.6.2.4.
The UK EEG Devices for Sleep and Sleep Architecture Market Revenue (US$
Mn) and Forecasts, By Application
13.6.2.4.1.
Clinical
13.6.2.4.1.1.
Insomnia
13.6.2.4.1.2.
Hypersomnia
13.6.2.4.1.3.
Other non-OSA sleep disorders
13.6.2.4.2. Research
13.6.2.4.2.1.
REM sleep without
Atonia in patients
with RBD
13.6.2.4.2.2.
Prodromal sleep biomarkers for neurodegenerative
disease
13.6.2.4.2.3.
Effect of Suvorexant progressive supranuclear
palsy
13.6.2.4.2.4.
Sleep patterns in patients with ICU delirium
13.6.3. Spain
13.6.2.4.2.5.
Sleep quality changes
as a result of cannabis
and opioid dependency
13.6.2.4.2.6.
Outcomes resulting from an insomnia
intervention 13.6.2.4.2.7. Influence of sleep deprivation on memory
13.6.2.4.2.8. Others
13.6.2.4.3.
Positional Sleep Apnea Therapy 13.6.2.4.4. Assess Sleep
Architecture and Continuity 13.6.2.4.5. Others
13.6.3.1.
Spain EEG Devices
for Sleep and Sleep Architecture Market Revenue (US$ Mn) and Forecasts, By Channels
13.6.3.1.1.
1 Channel
13.6.3.1.2.
4 Channels
13.6.3.1.3.
pay-per-use + 5 or 14 channels
13.6.3.1.4.
8 -16 Channels
13.6.3.1.5.
Above 16 Channels
13.6.3.2.
Spain EEG Devices
for Sleep and Sleep Architecture Market Revenue (US$ Mn) and Forecasts, By Offering
13.6.3.2.1.
Products
13.6.3.2.1.1.
Partially or fully Flexible Systems 13.6.3.2.1.2. Headcaps/Headsets
13.6.3.2.1.3.
Fixed Units
13.6.3.2.1.4.
Others
13.6.3.2.2.
Solution and Services
13.6.3.3.
Spain EEG Devices
for Sleep and Sleep Architecture Market Revenue (US$ Mn) and Forecasts, By End Use
13.6.3.3.1.
Research and Universities 13.6.3.3.2. In-Home
13.6.3.3.3.
Hospital/Clinics
13.6.3.3.4.
Businesses (Employers)
13.6.3.3.5.
Others
13.6.3.4.
Spain EEG Devices
for Sleep and Sleep Architecture Market Revenue (US$ Mn) and Forecasts, By Application
13.6.3.4.1.
Clinical
13.6.3.4.1.1.
Insomnia
13.6.3.4.1.2.
Hypersomnia
13.6.3.4.1.3.
Other non-OSA sleep disorders
13.6.3.4.2. Research
13.6.3.4.2.1.
REM sleep without
Atonia in patients
with RBD
13.6.3.4.2.2.
Prodromal sleep biomarkers for neurodegenerative
disease
13.6.3.4.2.3.
Effect of Suvorexant progressive supranuclear
palsy
13.6.3.4.2.4.
Sleep patterns in patients with ICU delirium 13.6.3.4.2.5. Sleep
quality changes as a result of cannabis
and
opioid dependency
13.6.3.4.2.6. Outcomes
resulting from an insomnia intervention 13.6.3.4.2.7. Influence of
sleep deprivation on memory 13.6.3.4.2.8. Others
13.6.3.4.3.
Positional Sleep Apnea Therapy 13.6.3.4.4. Assess Sleep
Architecture and Continuity 13.6.3.4.5. Others
13.6.4. Germany
13.6.4.1.
Germany EEG Devices
for Sleep and Sleep Architecture Market Revenue (US$ Mn) and Forecasts, By Channels
13.6.4.1.1.
1 Channel
13.6.4.1.2.
4 Channels
13.6.4.1.3.
pay-per-use + 5 or 14 channels
13.6.4.1.4.
8 -16 Channels
13.6.4.1.5.
Above 16 Channels
13.6.4.2.
Germany EEG Devices
for Sleep and Sleep Architecture Market Revenue (US$
Mn) and Forecasts, By Offering
13.6.4.2.1.
Products
13.6.4.2.1.1.
Partially or fully Flexible Systems 13.6.4.2.1.2. Headcaps/Headsets
13.6.4.2.1.3.
Fixed Units
13.6.4.2.1.4.
Others
13.6.4.2.2.
Solution and Services
13.6.4.3.
Germany EEG Devices
for Sleep and Sleep Architecture Market Revenue (US$
Mn) and Forecasts, By End Use
13.6.4.3.1.
Research and Universities 13.6.4.3.2. In-Home
13.6.4.3.3.
Hospital/Clinics
13.6.4.3.4.
Businesses (Employers)
13.6.4.3.5.
Others
13.6.4.4.
Germany EEG Devices
for Sleep and Sleep Architecture Market Revenue (US$
Mn) and Forecasts, By Application
13.6.4.4.1.
Clinical
13.6.4.4.1.1.
Insomnia
13.6.5. Italy
13.6.5.1.1.1.
Hypersomnia
13.6.5.1.1.2.
Other non-OSA sleep disorders
13.6.4.4.2. Research
13.6.4.4.2.1.
REM sleep without
Atonia in patients
with RBD
13.6.4.4.2.2.
Prodromal sleep biomarkers for neurodegenerative
disease
13.6.4.4.2.3.
Effect of Suvorexant progressive supranuclear
palsy
13.6.4.4.2.4.
Sleep patterns in patients with ICU delirium 13.6.4.4.2.5. Sleep
quality changes as a result of cannabis
and
opioid dependency
13.6.4.4.2.6. Outcomes
resulting from an insomnia intervention 13.6.4.4.2.7. Influence of
sleep deprivation on memory 13.6.4.4.2.8. Others
13.6.4.4.3.
Positional Sleep Apnea Therapy 13.6.4.4.4. Assess Sleep
Architecture and Continuity 13.6.4.4.5. Others
13.6.5.2.
Italy EEG Devices
for Sleep and Sleep Architecture Market Revenue (US$ Mn) and Forecasts, By Channels
13.6.5.2.1.
1 Channel
13.6.5.2.2.
4 Channels
13.6.5.2.3.
pay-per-use + 5 or 14 channels
13.6.5.2.4.
8 -16 Channels
13.6.5.2.5.
Above 16 Channels
13.6.5.3.
Italy EEG Devices
for Sleep and Sleep Architecture Market Revenue (US$ Mn) and Forecasts, By Offering
13.6.5.3.1.
Products
13.6.5.3.1.1.
Partially or fully Flexible Systems 13.6.5.2.1.2. Headcaps/Headsets
13.6.5.2.1.3.
Fixed Units
13.6.5.2.1.4.
Others
13.6.5.3.2.
Solution and Services
13.6.5.4.
Italy EEG Devices
for Sleep and Sleep Architecture Market Revenue (US$ Mn) and Forecasts, By End Use
13.6.5.4.1.
Research and Universities 13.6.5.3.2. In-Home
13.6.5.3.3.
Hospital/Clinics
13.6.5.3.4.
Businesses (Employers)
13.6.5.3.5.
Others
13.6.5.5.
Italy EEG Devices
for Sleep and Sleep
Architecture Market Revenue
(US$ Mn) and Forecasts, By Application
13.6.5.5.1.
Clinical
13.6.5.5.1.1.
Insomnia
13.6.5.5.1.2.
Hypersomnia
13.6.5.5.1.3.
Other non-OSA sleep disorders
13.6.5.4.2. Research
13.6.5.4.2.1.
REM sleep without
Atonia in patients
with RBD
13.6.5.4.2.2.
Prodromal sleep biomarkers for neurodegenerative
disease
13.6.5.4.2.3.
Effect of Suvorexant progressive supranuclear
palsy
13.6.5.4.2.4.
Sleep patterns in patients with ICU delirium 13.6.5.4.2.5. Sleep
quality changes as a result of cannabis
and
opioid dependency
13.6.5.4.2.6. Outcomes
resulting from an insomnia intervention 13.6.5.4.2.7. Influence of
sleep deprivation on memory 13.6.5.4.2.8. Others
13.6.5.4.3.
Positional Sleep Apnea Therapy 13.6.5.4.4. Assess Sleep
Architecture and Continuity 13.6.5.4.5. Others
13.6.6. Nordic Countries
13.6.6.1.
Nordic Countries EEG Devices for Sleep and Sleep Architecture Market Revenue (US$ Mn) and Forecasts, By Channels
13.6.6.1.1.
1 Channel
13.6.6.1.2.
4 Channels
13.6.6.1.3.
pay-per-use + 5 or 14 channels
13.6.6.1.4.
8 -16 Channels
13.6.6.1.5.
Above 16 Channels
13.6.6.2.
Nordic Countries EEG Devices for Sleep and Sleep Architecture Market Revenue (US$ Mn) and Forecasts, By Offering
13.6.6.2.1.
Products
13.6.6.2.1.1.
Partially or fully Flexible Systems 13.6.6.2.1.2. Headcaps/Headsets
13.6.6.2.1.3.
Fixed Units
13.6.6.2.1.4.
Others
13.6.6.2.2.
Solution and Services
13.6.6.3.
Nordic Countries EEG Devices for Sleep and Sleep Architecture Market Revenue (US$ Mn) and Forecasts, By End Use
13.6.6.3.1.
Research and Universities
13.6.6.3.2.
In-Home
13.6.6.3.3.
Hospital/Clinics
13.6.6.3.4.
Businesses (Employers)
13.6.6.3.5.
Others
13.6.6.4.
Nordic Countries EEG Devices for Sleep and Sleep Architecture Market Revenue (US$ Mn) and Forecasts, By Application
13.6.6.4.1.
Clinical
13.6.6.4.1.1.
Insomnia
13.6.6.4.1.2.
Hypersomnia
13.6.6.4.1.3.
Other non-OSA sleep disorders
13.6.6.4.2. Research
13.6.6.4.2.1.
REM sleep without
Atonia in patients
with RBD
13.6.6.4.2.2.
Prodromal sleep biomarkers for neurodegenerative
disease
13.6.6.4.2.3.
Effect of Suvorexant progressive supranuclear
palsy
13.6.6.4.2.4.
Sleep patterns in patients with ICU delirium 13.6.6.4.2.5. Sleep
quality changes as a result of cannabis
and
opioid dependency
13.6.6.4.2.6. Outcomes
resulting from an insomnia intervention 13.6.6.4.2.7. Influence of
sleep deprivation on memory 13.6.6.4.2.8. Others
13.6.6.4.3.
Positional Sleep Apnea Therapy 13.6.6.4.4. Assess Sleep
Architecture and Continuity 13.6.6.4.5. Others
13.6.6.5.
Nordic Countries EEG Devices for Sleep and Sleep Architecture Market Revenue (US$ Mn) and Forecasts, By Country
13.6.6.5.1.
Denmark
13.6.6.5.2.
Finland
13.6.6.5.3.
Iceland
13.6.6.5.4.
Sweden
13.6.6.5.5.
Norway
13.6.7.
Benelux Union
13.6.7.1.
Benelux Union EEG Devices for Sleep and Sleep Architecture Market Revenue (US$ Mn) and Forecasts, By Channels
13.6.7.1.1.
1 Channel
13.6.7.1.2.
4 Channels
13.6.7.1.3.
pay-per-use + 5 or 14 channels
13.6.7.1.4.
8 -16 Channels
13.6.7.1.5.
Above 16 Channels
13.6.7.2.
Benelux Union EEG Devices for Sleep and Sleep Architecture Market Revenue (US$ Mn) and Forecasts, By Offering
13.6.7.2.1.
Products
13.6.7.2.1.1.
Partially or fully Flexible Systems 13.6.7.2.1.2. Headcaps/Headsets
13.6.7.2.1.3.
Fixed Units
13.6.7.2.1.4.
Others
13.6.7.2.2.
Solution and Services
13.6.7.3.
Benelux Union EEG Devices for Sleep and Sleep Architecture Market Revenue (US$ Mn) and Forecasts, By End Use
13.6.7.3.1.
Research and Universities 13.6.7.3.2. In-Home
13.6.7.3.3.
Hospital/Clinics
13.6.7.3.4.
Businesses (Employers)
13.6.7.3.5.
Others
13.6.7.4.
Benelux Union EEG Devices for Sleep and Sleep Architecture Market Revenue (US$ Mn) and Forecasts, By Application
13.6.7.4.1.
Clinical
13.6.7.4.1.1.
Insomnia
13.6.7.4.1.2.
Hypersomnia
13.6.7.4.1.3.
Other non-OSA sleep disorders
13.6.7.4.2. Research
13.6.7.4.2.1.
REM sleep without
Atonia in patients
with RBD
13.6.7.4.2.2.
Prodromal sleep biomarkers for neurodegenerative
disease
13.6.7.4.2.3.
Effect of Suvorexant progressive supranuclear
palsy
13.6.7.4.2.4.
Sleep patterns in patients with ICU delirium 13.6.7.4.2.5. Sleep
quality changes as a result of cannabis
and
opioid dependency
13.6.7.4.2.6. Outcomes
resulting from an insomnia intervention 13.6.7.4.2.7. Influence of
sleep deprivation on memory 13.6.7.4.2.8. Others
13.6.7.4.3. Positional
Sleep Apnea Therapy 13.6.7.4.4. Assess Sleep
Architecture and Continuity 13.6.7.4.5. Others
13.6.7.5.
Benelux Union EEG Devices for Sleep and Sleep Architecture Market Revenue (US$ Mn) and Forecasts, By Country
13.6.7.5.1.
Belgium
13.6.7.5.2.
The Netherlands
13.6.7.5.3.
Luxembourg
13.6.8.
Rest of Europe
13.6.8.1.
Rest of Europe
EEG Devices for Sleep and Sleep Architecture Market Revenue (US$ Mn) and Forecasts, By Channels
13.6.8.1.1.
1 Channel
13.6.8.1.2.
4 Channels
13.6.8.1.3.
pay-per-use + 5 or 14 channels
13.6.8.1.4.
8 -16 Channels
13.6.8.1.5.
Above 16 Channels
13.6.8.2.
Rest of Europe
EEG Devices for Sleep and Sleep Architecture Market Revenue (US$ Mn) and Forecasts, By Offering
13.6.8.2.1.
Products
13.6.8.2.1.1.
Partially or fully Flexible Systems 13.6.8.2.1.2. Headcaps/Headsets
13.6.8.2.1.3.
Fixed Units
13.6.8.2.1.4.
Others
13.6.8.2.2.
Solution and Services
13.6.8.3.
Rest of Europe
EEG Devices for Sleep and Sleep Architecture Market Revenue (US$ Mn) and Forecasts, By End Use
13.6.8.3.1.
Research and Universities 13.6.8.3.2. In-Home
13.6.8.3.3.
Hospital/Clinics
13.6.8.3.4.
Businesses (Employers)
13.6.8.3.5.
Others
13.6.8.4.
Rest of Europe
EEG Devices for Sleep and Sleep Architecture Market Revenue (US$ Mn) and Forecasts, By Application
13.6.8.4.1.
Clinical
13.6.8.4.1.1.
Insomnia
13.6.8.4.1.2.
Hypersomnia
13.6.8.4.1.3.
Other non-OSA sleep disorders
13.6.8.4.2. Research
13.6.8.4.2.1.
REM sleep without
Atonia in patients
with RBD
13.6.8.4.2.2.
Prodromal sleep biomarkers for neurodegenerative
disease
13.6.8.4.2.3.
Effect of Suvorexant progressive supranuclear
palsy
13.6.8.4.2.4.
Sleep patterns in patients with ICU delirium 13.6.8.4.2.5. Sleep
quality changes as a result of cannabis
and
opioid dependency
13.6.8.4.2.6.
Outcomes resulting from an insomnia
intervention
13.6.8.4.2.7.
Influence of sleep
deprivation on memory 13.6.8.4.2.8. Others
13.6.8.4.3.
Positional Sleep Apnea Therapy 13.6.8.4.4. Assess Sleep Architecture and Continuity
13.6.8.4.5. Others
13.7.
Key Segment for Channeling Investments
13.7.1.
By Country
13.7.2.
By Channels
13.7.3.
By Offering
13.7.4. By End Use
13.7.5.
By Application
14.
Asia Pacific EEG Devices for Sleep and Sleep
Architecture Market Analysis and Forecasts,
2022 – 2030
14.1.
Overview
14.1.1.
Asia Pacific EEG Devices for Sleep and Sleep Architecture Market Revenue (US$ Mn)
14.2.
Asia Pacific EEG Devices for Sleep and Sleep
Architecture Market Revenue
(US$ Mn) and Forecasts, By Channels
14.2.1. 1 Channel
14.2.2. 4 Channels
14.2.3.
pay-per-use + 5 or 14 channels
14.2.4.
8 -16 Channels
14.2.5. Above 16 Channels
14.3.
Asia Pacific EEG Devices for Sleep and Sleep
Architecture Market Revenue
(US$ Mn) and Forecasts, By
Offering
14.3.1. Products
14.3.1.1.
Partially or fully Flexible Systems
14.3.1.2.
Headcaps/Headsets
14.3.1.3.
Fixed Units
14.3.1.4.
Others
14.3.2. Solution and Services
14.4.
Asia Pacific EEG Devices for Sleep and Sleep
Architecture Market Revenue
(US$ Mn) and Forecasts, By
End Use
14.4.1. Research and Universities
14.4.2.
In-Home
14.4.3. Hospital/Clinics
14.4.4.
Businesses (Employers)
14.4.5.
Others
14.5.
Asia Pacific EEG Devices for Sleep and Sleep
Architecture Market Revenue
(US$ Mn) and Forecasts, By
Application
14.5.1. Clinical
14.5.1.1.
Insomnia
14.5.1.2.
Hypersomnia
14.5.1.3.
Other non-OSA sleep disorders
14.5.2.
Research
14.5.2.1.
REM sleep without
Atonia in patients
with RBD
14.5.2.2.
Prodromal sleep biomarkers for neurodegenerative disease
14.5.2.3.
Effect of Suvorexant progressive supranuclear palsy
14.5.2.4.
Sleep patterns in patients with ICU delirium
14.5.2.5.
Sleep quality changes
as a result of cannabis
and opioid dependency
14.5.2.6.
Outcomes resulting from an insomnia
intervention
14.5.2.7.
Influence of sleep
deprivation on memory
14.5.2.8.
Others
14.5.3. Positional Sleep Apnea Therapy
14.5.4.
Assess Sleep Architecture and Continuity
14.5.5.
Others
14.6.
Asia Pacific EEG Devices for Sleep and Sleep
Architecture Market Revenue
(US$ Mn) and Forecasts, By
Country
14.6.1. China
14.6.1.1.
China EEG Devices
for Sleep and Sleep Architecture Market Revenue (US$
Mn) and Forecasts, By Channels
14.6.1.1.1.
1 Channel
14.6.1.1.2.
4 Channels
14.6.1.1.3.
pay-per-use + 5 or 14 channels
14.6.1.1.4.
8 -16 Channels
14.6.1.1.5.
Above 16 Channels
14.6.1.2.
China EEG Devices
for Sleep and Sleep Architecture Market Revenue (US$
Mn) and Forecasts, By Offering
14.6.1.2.1.
Products
14.6.1.2.1.1.
Partially or fully Flexible Systems 14.6.1.2.1.2. Headcaps/Headsets
14.6.1.2.1.3.
Fixed Units
14.6.1.2.1.4.
Others
14.6.1.2.2.
Solution and Services
14.6.1.3.
China EEG Devices
for Sleep and Sleep Architecture Market Revenue (US$
Mn) and Forecasts, By End Use
14.6.1.3.1.
Research and Universities 14.6.1.3.2. In-Home
14.6.1.3.3.
Hospital/Clinics
14.6.1.3.4.
Businesses (Employers)
14.6.1.3.5.
Others
14.6.1.4.
China EEG Devices
for Sleep and Sleep Architecture Market Revenue (US$
Mn) and Forecasts, By Application
14.6.1.4.1.
Clinical
14.6.1.4.1.1.
Insomnia
14.6.1.4.1.2.
Hypersomnia
14.6.1.4.1.3.
Other non-OSA sleep disorders
14.6.1.4.2. Research
14.6.1.4.2.1.
REM sleep without
Atonia in patients
with RBD
14.6.1.4.2.2.
Prodromal sleep biomarkers for neurodegenerative
disease
14.6.1.4.2.3.
Effect of Suvorexant progressive supranuclear
palsy
14.6.1.4.2.4.
Sleep patterns in patients with ICU delirium 14.6.1.4.2.5. Sleep
quality changes as a result of cannabis
and
opioid dependency
14.6.1.4.2.6. Outcomes
resulting from an insomnia intervention 14.6.1.4.2.7. Influence of
sleep deprivation on memory 14.6.1.4.2.8. Others
14.6.1.4.3.
Positional Sleep Apnea Therapy 14.6.1.4.4. Assess Sleep Architecture and Continuity
14.6.1.4.5. Others
14.6.2. Japan
14.6.2.1.
Japan EEG Devices
for Sleep and Sleep Architecture Market Revenue (US$
Mn) and Forecasts, By Channels
14.6.2.1.1.
1 Channel
14.6.2.1.2.
4 Channels
14.6.2.1.3.
pay-per-use + 5 or 14 channels
14.6.2.1.4.
8 -16 Channels
14.6.2.1.5.
Above 16 Channels
14.6.2.2.
Japan EEG Devices
for Sleep and Sleep Architecture Market Revenue (US$
Mn) and Forecasts, By Offering
14.6.2.2.1.
Products
14.6.2.2.1.1.
Partially or fully Flexible Systems 14.6.2.2.1.2. Headcaps/Headsets
14.6.2.2.1.3.
Fixed Units
14.6.2.2.1.4.
Others
14.6.2.2.2.
Solution and Services
14.6.2.3.
Japan EEG Devices
for Sleep and Sleep Architecture Market Revenue (US$
Mn) and Forecasts, By End Use
14.6.2.3.1.
Research and Universities 14.6.2.3.2. In-Home
14.6.2.3.3.
Hospital/Clinics
14.6.2.3.4.
Businesses (Employers)
14.6.2.3.5.
Others
14.6.2.4.
Japan EEG Devices
for Sleep and Sleep Architecture Market Revenue (US$
Mn) and Forecasts, By Application
14.6.2.4.1.
Clinical
14.6.2.4.1.1.
Insomnia
14.6.2.4.1.2.
Hypersomnia
14.6.2.4.1.3.
Other non-OSA sleep
disorders 14.6.2.4.2. Research
14.6.2.4.2.1.
REM sleep without
Atonia in patients
with RBD
14.6.2.4.2.2.
Prodromal sleep biomarkers for neurodegenerative
disease
14.6.2.4.2.3.
Effect of Suvorexant progressive supranuclear
palsy
14.6.2.4.2.4.
Sleep patterns in patients with ICU delirium 14.6.2.4.2.5. Sleep quality changes
as a result of cannabis
and
opioid dependency
14.6.2.4.2.6. Outcomes
resulting from an insomnia intervention 14.6.2.4.2.7. Influence of
sleep deprivation on memory 14.6.2.4.2.8. Others
14.6.2.4.3.
Positional Sleep Apnea Therapy 14.6.2.4.4. Assess Sleep
Architecture and Continuity 14.6.2.4.5. Others
14.6.3. India
14.6.3.1.
India EEG Devices
for Sleep and Sleep
Architecture Market Revenue
(US$ Mn) and Forecasts, By Channels
14.6.3.1.1.
1 Channel
14.6.3.1.2.
4 Channels
14.6.3.1.3.
pay-per-use + 5 or 14 channels
14.6.3.1.4.
8 -16 Channels
14.6.3.1.5.
Above 16 Channels
14.6.3.2.
India EEG Devices
for Sleep and Sleep Architecture Market Revenue (US$ Mn) and Forecasts, By Offering
14.6.3.2.1.
Products
14.6.3.2.1.1.
Partially or fully Flexible Systems 14.6.3.2.1.2. Headcaps/Headsets
14.6.3.2.1.3.
Fixed Units
14.6.3.2.1.4.
Others
14.6.3.2.2.
Solution and Services
14.6.3.3.
India EEG Devices
for Sleep and Sleep Architecture Market Revenue (US$ Mn) and Forecasts, By End Use
14.6.3.3.1.
Research and Universities 14.6.3.3.2. In-Home
14.6.3.3.3.
Hospital/Clinics
14.6.3.3.4.
Businesses (Employers)
14.6.3.3.5.
Others
14.6.3.4.
India EEG Devices
for Sleep and Sleep Architecture Market Revenue (US$ Mn) and Forecasts, By Application
14.6.3.4.1.
Clinical
14.6.3.4.1.1.
Insomnia
14.6.3.4.1.2.
Hypersomnia
14.6.3.4.1.3.
Other non-OSA sleep disorders
14.6.3.4.2. Research
14.6.3.4.2.1.
REM sleep without
Atonia in patients
with RBD
14.6.3.4.2.2.
Prodromal sleep biomarkers for neurodegenerative
disease
14.6.3.4.2.3.
Effect of Suvorexant progressive supranuclear
palsy
14.6.3.4.2.4.
Sleep patterns in patients with ICU delirium 14.6.3.4.2.5. Sleep
quality changes as a result of cannabis
and
opioid dependency
14.6.3.4.2.6. Outcomes
resulting from an insomnia intervention 14.6.3.4.2.7. Influence of
sleep deprivation on memory 14.6.3.4.2.8. Others
14.6.3.4.3.
Positional Sleep Apnea Therapy 14.6.3.4.4. Assess Sleep
Architecture and Continuity 14.6.3.4.5. Others
14.6.4. New Zealand
14.6.4.1.
New Zealand EEG Devices for Sleep and Sleep Architecture Market Revenue (US$ Mn) and Forecasts, By Channels
14.6.4.1.1.
1 Channel
14.6.4.1.2.
4 Channels
14.6.4.1.3.
pay-per-use + 5 or 14 channels
14.6.4.1.4.
8 -16 Channels
14.6.4.1.5.
Above 16 Channels
14.6.4.2.
New Zealand EEG Devices for Sleep and Sleep Architecture Market Revenue (US$ Mn) and Forecasts, By Offering
14.6.4.2.1.
Products
14.6.4.2.1.1.
Partially or fully Flexible Systems 14.6.4.2.1.2. Headcaps/Headsets
14.6.4.2.1.3.
Fixed Units
14.6.4.2.1.4.
Others
14.6.4.2.2.
Solution and Services
14.6.4.3.
New Zealand EEG Devices for Sleep and Sleep Architecture Market Revenue (US$ Mn) and Forecasts, By End Use
14.6.4.3.1.
Research and Universities 14.6.4.3.2. In-Home
14.6.4.3.3.
Hospital/Clinics
14.6.4.3.4.
Businesses (Employers)
14.6.4.3.5.
Others
14.6.4.4.
New Zealand EEG Devices for Sleep and Sleep Architecture Market Revenue (US$ Mn) and Forecasts, By Application
14.6.4.4.1.
Clinical
14.6.4.4.1.1.
Insomnia
14.6.4.4.1.2.
Hypersomnia
14.6.4.4.1.3.
Other non-OSA sleep disorders
14.6.4.4.2. Research
14.6.4.4.2.1.
REM sleep without
Atonia in patients
with RBD
14.6.4.4.2.2.
Prodromal sleep biomarkers for neurodegenerative
disease
14.6.4.4.2.3.
Effect of Suvorexant progressive supranuclear
palsy
14.6.4.4.2.4.
Sleep patterns in patients with ICU delirium 14.6.4.4.2.5. Sleep
quality changes as a result of cannabis
and
opioid dependency
14.6.4.4.2.6. Outcomes
resulting from an insomnia intervention 14.6.4.4.2.7. Influence of
sleep deprivation on memory 14.6.4.4.2.8. Others
14.6.4.4.3.
Positional Sleep Apnea Therapy 14.6.4.4.4. Assess Sleep
Architecture and Continuity 14.6.4.4.5. Others
14.6.5. Australia
14.6.5.1.
Australia EEG Devices
for Sleep and Sleep Architecture Market Revenue (US$
Mn) and Forecasts, By Channels
14.6.5.1.1.
1 Channel
14.6.5.1.2.
4 Channels
14.6.5.1.3.
pay-per-use + 5 or 14 channels
14.6.5.1.4.
8 -16 Channels
14.6.5.1.5.
Above 16 Channels
14.6.5.2.
Australia EEG Devices
for Sleep and Sleep Architecture Market Revenue (US$
Mn) and Forecasts, By Offering
14.6.5.2.1.
Products
14.6.5.2.1.1.
Partially or fully Flexible Systems 14.6.5.2.1.2. Headcaps/Headsets
14.6.5.2.1.3.
Fixed Units
14.6.5.2.1.4.
Others
14.6.5.2.2.
Solution and Services
14.6.5.3.
Australia EEG Devices
for Sleep and Sleep Architecture Market Revenue (US$
Mn) and Forecasts, By End Use
14.6.5.3.1.
Research and Universities 14.6.5.3.2. In-Home
14.6.5.3.3.
Hospital/Clinics
14.6.5.3.4.
Businesses (Employers)
14.6.5.3.5.
Others
14.6.5.4.
Australia EEG Devices
for Sleep and Sleep Architecture Market Revenue (US$
Mn) and Forecasts, By Application
14.6.5.4.1.
Clinical
14.6.5.4.1.1.
Insomnia
14.6.5.4.1.2.
Hypersomnia
14.6.5.4.1.3.
Other non-OSA sleep disorders
14.6.5.4.2. Research
14.6.5.4.2.1.
REM sleep without
Atonia in patients
with RBD
14.6.5.4.2.2.
Prodromal sleep biomarkers for neurodegenerative
disease
14.6.5.4.2.3.
Effect of Suvorexant progressive supranuclear
palsy
14.6.5.4.2.4.
Sleep patterns in patients with ICU delirium 14.6.5.4.2.5. Sleep
quality changes as a result of cannabis
and
opioid dependency
14.6.5.4.2.6. Outcomes
resulting from an insomnia intervention 14.6.5.4.2.7. Influence of
sleep deprivation on memory 14.6.5.4.2.8. Others
14.6.5.4.3.
Positional Sleep Apnea Therapy 14.6.5.4.4. Assess Sleep Architecture and Continuity
14.6.5.4.5. Others
14.6.6. South Korea
14.6.6.1.
South Korea EEG Devices for Sleep and Sleep Architecture Market Revenue (US$ Mn) and Forecasts, By Channels
14.6.6.1.1.
1 Channel
14.6.6.1.2.
4 Channels
14.6.6.1.3.
pay-per-use + 5 or 14 channels
14.6.6.1.4.
8 -16 Channels
14.6.6.1.5.
Above 16 Channels
14.6.6.2.
South Korea EEG Devices
for Sleep and Sleep Architecture Market Revenue (US$ Mn) and Forecasts, By Offering
14.6.6.2.1.
Products
14.6.6.2.1.1.
Partially or fully Flexible Systems 14.6.6.2.1.2. Headcaps/Headsets
14.6.6.2.1.3.
Fixed Units
14.6.6.2.1.4.
Others
14.6.6.2.2.
Solution and Services
14.6.6.3.
South Korea EEG Devices for Sleep and Sleep Architecture Market Revenue (US$ Mn) and Forecasts, By End Use
14.6.6.3.1.
Research and Universities 14.6.6.3.2. In-Home
14.6.6.3.3.
Hospital/Clinics
14.6.6.3.4.
Businesses (Employers)
14.6.6.3.5.
Others
14.6.6.4.
South Korea EEG Devices for Sleep and Sleep Architecture Market Revenue (US$ Mn) and Forecasts, By Application
14.6.6.4.1.
Clinical
14.6.6.4.1.1.
Insomnia
14.6.6.4.1.2.
Hypersomnia
14.6.6.4.1.3.
Other non-OSA sleep disorders
14.6.6.4.2. Research
14.6.6.4.2.1.
REM sleep without
Atonia in patients
with RBD
14.6.6.4.2.2.
Prodromal sleep biomarkers for neurodegenerative
disease
14.6.6.4.2.3.
Effect of Suvorexant progressive supranuclear
palsy
14.6.6.4.2.4.
Sleep patterns in patients with ICU delirium 14.6.6.4.2.5. Sleep quality changes
as a result of cannabis
and
opioid dependency
14.6.6.4.2.6. Outcomes
resulting from an insomnia intervention 14.6.6.4.2.7. Influence of
sleep deprivation on memory 14.6.6.4.2.8. Others
14.6.6.4.3.
Positional Sleep Apnea Therapy 14.6.6.4.4. Assess Sleep
Architecture and Continuity 14.6.6.4.5. Others
14.6.7. Southeast Asia
14.6.7.1.
Southeast Asia EEG Devices for Sleep and Sleep Architecture Market Revenue (US$ Mn) and Forecasts, By Channels
14.6.7.1.1.
1 Channel
14.6.7.1.2.
4 Channels
14.6.7.1.3.
pay-per-use + 5 or 14 channels
14.6.7.1.4.
8 -16 Channels
14.6.7.1.5.
Above 16 Channels
14.6.7.2.
Southeast Asia EEG Devices for Sleep and Sleep Architecture Market Revenue (US$ Mn) and
Forecasts, By Offering
14.6.7.2.1.
Products
14.6.7.2.1.1.
Partially or fully Flexible Systems 14.6.7.2.1.2. Headcaps/Headsets
14.6.7.2.1.3.
Fixed Units
14.6.7.2.1.4.
Others
14.6.7.2.2.
Solution and Services
14.6.7.3.
Southeast Asia EEG Devices for Sleep and Sleep Architecture Market Revenue (US$ Mn) and Forecasts, By End Use
14.6.7.3.1.
Research and Universities 14.6.7.3.2. In-Home
14.6.7.3.3.
Hospital/Clinics
14.6.7.3.4.
Businesses (Employers)
14.6.7.3.5.
Others
14.6.7.4.
Southeast Asia EEG Devices for Sleep and Sleep Architecture Market Revenue (US$ Mn) and Forecasts, By Application
14.6.7.4.1.
Clinical
14.6.7.4.1.1.
Insomnia
14.6.7.4.1.2.
Hypersomnia
14.6.7.4.1.3.
Other non-OSA sleep
disorders 14.6.7.4.2. Research
14.6.7.4.2.1.
REM sleep without
Atonia in patients
with RBD
14.6.7.4.2.2.
Prodromal sleep biomarkers for neurodegenerative
disease
14.6.7.4.2.3.
Effect of Suvorexant progressive supranuclear
palsy
14.6.7.4.2.4.
Sleep patterns in patients with ICU delirium
14.6.7.4.2.5.
Sleep quality changes
as a result of cannabis
and opioid dependency
14.6.7.4.2.6.
Outcomes resulting from an insomnia
intervention 14.6.7.4.2.7. Influence of sleep deprivation on memory
14.6.7.4.2.8. Others
14.6.7.4.3.
Positional Sleep Apnea Therapy 14.6.7.4.4. Assess Sleep
Architecture and Continuity 14.6.7.4.5. Others
14.6.7.5.
Southeast Asia EEG Devices for Sleep and Sleep
Architecture Market Revenue (US$ Mn)
and Forecasts, By Country
14.6.7.5.1.
Indonesia
14.6.7.5.2.
Thailand
14.6.7.5.3.
Malaysia
14.6.7.5.4.
Singapore
14.6.7.5.5.
Rest of Southeast Asia
14.6.8.
Rest of Asia Pacific
14.6.8.1.
Rest of Asia Pacific EEG Devices for Sleep and Sleep
Architecture Market Revenue (US$ Mn)
and Forecasts, By Channels
14.6.8.1.1.
1 Channel
14.6.8.1.2.
4 Channels
14.6.8.1.3.
pay-per-use + 5 or 14 channels
14.6.8.1.4.
8 -16 Channels
14.6.8.1.5.
Above 16 Channels
14.6.8.2.
Rest of Asia Pacific EEG Devices for Sleep and Sleep
Architecture Market Revenue (US$ Mn)
and Forecasts, By Offering
14.6.8.2.1.
Products
14.6.8.2.1.1.
Partially or fully Flexible Systems 14.6.8.2.1.2. Headcaps/Headsets
14.6.8.2.1.3.
Fixed Units
14.6.8.2.1.4.
Others
14.6.8.2.2.
Solution and Services
14.6.8.3.
Rest of Asia Pacific EEG Devices for Sleep and Sleep
Architecture Market Revenue (US$ Mn)
and Forecasts, By End Use
14.6.8.3.1.
Research and Universities 14.6.8.3.2. In-Home
14.6.8.3.3.
Hospital/Clinics
14.6.8.3.4.
Businesses (Employers)
14.6.8.3.5.
Others
14.6.8.4.
Rest of Asia Pacific EEG Devices for Sleep and Sleep
Architecture Market Revenue (US$ Mn)
and Forecasts, By Application
14.6.8.4.1.
Clinical
14.6.8.4.1.1.
Insomnia
14.6.8.4.1.2.
Hypersomnia
14.6.8.4.1.3.
Other non-OSA sleep disorders
14.6.8.4.2. Research
14.6.8.4.2.1.
REM sleep without
Atonia in patients
with RBD
14.6.8.4.2.2.
Prodromal sleep biomarkers for neurodegenerative
disease
14.6.8.4.2.3.
Effect of Suvorexant progressive supranuclear
palsy
14.6.8.4.2.4.
Sleep patterns in patients with ICU delirium 14.6.8.4.2.5. Sleep
quality changes as a result of cannabis
and
opioid dependency
14.6.8.4.2.6. Outcomes
resulting from an insomnia intervention 14.6.8.4.2.7. Influence of
sleep deprivation on memory 14.6.8.4.2.8. Others
14.6.8.4.3.
Positional Sleep Apnea Therapy 14.6.8.4.4. Assess Sleep
Architecture and Continuity 14.6.8.4.5. Others
14.7.
Key Segment for Channeling Investments
14.7.1.
By Country
14.7.2.
By Channels
14.7.3. By Offering
14.7.4.
By End Use
14.7.5.
By Application
15.
Middle East and Africa EEG Devices for Sleep and Sleep Architecture Market Analysis and Forecasts, 2022 – 2030
15.1.
Overview
15.1.1.
Middle East and Africa
EEG Devices for Sleep and Sleep
Architecture Market Revenue (US$ Mn)
15.2.
Middle East and Africa
EEG Devices for Sleep and Sleep
Architecture Market Revenue (US$ Mn)
and Forecasts, By Channels
15.2.1. 1 Channel
15.2.2. 4 Channels
15.2.3.
pay-per-use + 5 or 14 channels
15.2.4.
8 -16 Channels
15.2.5. Above 16 Channels
15.3.
Middle East and Africa
EEG Devices for Sleep and Sleep
Architecture Market Revenue (US$ Mn) and Forecasts, By
Offering
15.3.1. Products
15.3.1.1.
Partially or fully Flexible Systems
15.3.1.2.
Headcaps/Headsets
15.3.1.3.
Fixed Units
15.3.1.4.
Others
15.3.2.
Solution and Services
15.4.
Middle East and Africa
EEG Devices for Sleep and Sleep
Architecture Market Revenue (US$ Mn) and Forecasts, By End Use
15.4.1. Research and Universities
15.4.2.
In-Home
15.4.3. Hospital/Clinics
15.4.4.
Businesses (Employers)
15.4.5. Others
15.5.
Middle East and Africa
EEG Devices for Sleep and Sleep
Architecture Market Revenue (US$ Mn) and Forecasts, By
Application
15.5.1. Clinical
15.5.1.1.
Insomnia
15.5.1.2.
Hypersomnia
15.5.1.3.
Other non-OSA sleep disorders
15.5.2.
Research
15.5.2.1.
REM sleep without
Atonia in patients
with RBD
15.5.2.2.
Prodromal sleep biomarkers for neurodegenerative disease
15.5.2.3.
Effect of Suvorexant progressive supranuclear palsy
15.5.2.4.
Sleep patterns in patients with ICU delirium
15.5.2.5.
Sleep quality changes
as a result of cannabis
and opioid dependency
15.5.2.6.
Outcomes resulting from an insomnia
intervention
15.5.2.7.
Influence of sleep
deprivation on memory
15.5.2.8.
Others
15.5.3. Positional Sleep Apnea Therapy
15.5.4.
Assess Sleep Architecture and Continuity
15.5.5.
Others
15.6.
Middle East and Africa
EEG Devices for Sleep and Sleep
Architecture Market Revenue (US$ Mn) and Forecasts, By Country
15.6.1. Saudi Arabia
15.6.1.1.
Saudi Arabia EEG Devices for Sleep and Sleep Architecture Market Revenue (US$ Mn) and Forecasts, By Channels
15.6.1.1.1.
1 Channel
15.6.1.1.2.
4 Channels
15.6.1.1.3.
pay-per-use + 5 or 14 channels
15.6.1.1.4.
8 -16 Channels
15.6.1.1.5.
Above 16 Channels
15.6.1.2.
Saudi Arabia EEG Devices
for Sleep and Sleep Architecture Market Revenue (US$ Mn) and Forecasts, By Offering
15.6.1.2.1.
Products
15.6.1.2.1.1.
Partially or fully Flexible Systems 15.6.1.2.1.2. Headcaps/Headsets
15.6.1.2.1.3.
Fixed Units
15.6.1.2.1.4.
Others
15.6.1.2.2.
Solution and Services
15.6.1.3.
Saudi Arabia EEG Devices for Sleep and Sleep Architecture Market Revenue (US$ Mn) and Forecasts, By End Use
15.6.1.3.1.
Research and Universities 15.6.1.3.2. In-Home
15.6.1.3.3.
Hospital/Clinics
15.6.1.3.4.
Businesses (Employers)
15.6.1.3.5.
Others
15.6.1.4.
Saudi Arabia EEG Devices for Sleep and Sleep Architecture Market Revenue (US$ Mn) and Forecasts, By Application
15.6.1.4.1.
Clinical
15.6.1.4.1.1.
Insomnia
15.6.1.4.1.2.
Hypersomnia
15.6.1.4.1.3.
Other non-OSA sleep disorders
15.6.1.4.2. Research
15.6.1.4.2.1.
REM sleep without
Atonia in patients
with RBD
15.6.1.4.2.2.
Prodromal sleep biomarkers for neurodegenerative
disease
15.6.1.4.2.3.
Effect of Suvorexant progressive supranuclear
palsy
15.6.1.4.2.4.
Sleep patterns in patients with ICU delirium 15.6.1.4.2.5. Sleep quality changes
as a result of cannabis
and
opioid dependency
15.6.1.4.2.6. Outcomes
resulting from an insomnia intervention 15.6.1.4.2.7. Influence of
sleep deprivation on memory 15.6.1.4.2.8. Others
15.6.1.4.3.
Positional Sleep Apnea Therapy 15.6.1.4.4. Assess Sleep
Architecture and Continuity 15.6.1.4.5. Others
15.6.2. UAE
15.6.2.1.
UAE EEG Devices
for Sleep and Sleep Architecture Market Revenue (US$ Mn) and Forecasts, By Channels
15.6.2.1.1.
1 Channel
15.6.2.1.2.
4 Channels
15.6.2.1.3.
pay-per-use + 5 or 14 channels
15.6.2.1.4.
8 -16 Channels
15.6.2.1.5.
Above 16 Channels
15.6.2.2.
UAE EEG Devices
for Sleep and Sleep Architecture Market Revenue (US$ Mn) and Forecasts, By Offering
15.6.2.2.1.
Products
15.6.2.2.1.1.
Partially or fully Flexible Systems 15.6.2.2.1.2. Headcaps/Headsets
15.6.2.2.1.3.
Fixed Units
15.6.2.2.1.4.
Others
15.6.2.2.2.
Solution and Services
15.6.2.3.
UAE EEG Devices
for Sleep and Sleep Architecture Market Revenue (US$ Mn) and Forecasts, By End Use
15.6.2.3.1.
Research and Universities 15.6.2.3.2. In-Home
15.6.2.3.3.
Hospital/Clinics
15.6.2.3.4.
Businesses (Employers)
15.6.2.3.5.
Others
15.6.2.4.
UAE EEG Devices
for Sleep and Sleep Architecture Market Revenue (US$ Mn) and Forecasts, By Application
15.6.2.4.1.
Clinical
15.6.2.4.1.1.
Insomnia
15.6.2.4.1.2.
Hypersomnia
15.6.2.4.1.3.
Other non-OSA sleep disorders
15.6.2.4.2. Research
15.6.2.4.2.1.
REM sleep without
Atonia in patients
with RBD
15.6.2.4.2.2.
Prodromal sleep biomarkers for neurodegenerative
disease
15.6.2.4.2.3.
Effect of Suvorexant progressive supranuclear
palsy
15.6.2.4.2.4.
Sleep patterns in patients with ICU delirium 15.6.2.4.2.5. Sleep
quality changes as a result of cannabis
and
opioid dependency
15.6.2.4.2.6. Outcomes
resulting from an insomnia intervention 15.6.2.4.2.7. Influence of
sleep deprivation on memory 15.6.2.4.2.8. Others
15.6.2.4.3. Positional
Sleep Apnea Therapy 15.6.2.4.4. Assess Sleep
Architecture and Continuity 15.6.2.4.5. Others
15.6.3. Egypt
15.6.3.1.
Egypt EEG Devices
for Sleep and Sleep Architecture Market Revenue (US$ Mn) and Forecasts, By Channels
15.6.3.1.1.
1 Channel
15.6.3.1.2.
4 Channels
15.6.3.1.3.
pay-per-use + 5 or 14 channels
15.6.3.1.4.
8 -16 Channels
15.6.3.1.5.
Above 16 Channels
15.6.3.2.
Egypt EEG Devices
for Sleep and Sleep Architecture Market Revenue (US$ Mn) and Forecasts, By Offering
15.6.3.2.1.
Products
15.6.3.2.1.1.
Partially or fully Flexible Systems 15.6.3.2.1.2. Headcaps/Headsets
15.6.3.2.1.3.
Fixed Units
15.6.3.2.1.4.
Others
15.6.3.2.2.
Solution and Services
15.6.3.3.
Egypt EEG Devices
for Sleep and Sleep Architecture Market Revenue (US$ Mn) and Forecasts, By End Use
15.6.3.3.1.
Research and Universities 15.6.3.3.2. In-Home
15.6.3.3.3.
Hospital/Clinics
15.6.3.3.4.
Businesses (Employers)
15.6.3.3.5.
Others
15.6.3.4.
Egypt EEG Devices
for Sleep and Sleep
Architecture Market Revenue
(US$ Mn) and Forecasts, By Application
15.6.3.4.1.
Clinical
15.6.3.4.1.1.
Insomnia
15.6.3.4.1.2.
Hypersomnia
15.6.3.4.1.3.
Other non-OSA sleep disorders
15.6.3.4.2. Research
15.6.3.4.2.1.
REM sleep without
Atonia in patients
with RBD
15.6.3.4.2.2.
Prodromal sleep biomarkers for neurodegenerative
disease
15.6.3.4.2.3.
Effect of Suvorexant progressive supranuclear
palsy
15.6.3.4.2.4.
Sleep patterns in patients with ICU delirium 15.6.3.4.2.5. Sleep
quality changes as a result of cannabis
and
opioid dependency
15.6.3.4.2.6. Outcomes
resulting from an insomnia intervention 15.6.3.4.2.7. Influence of
sleep deprivation on memory
15.6.4. Kuwait
15.6.3.4.2.8. Others
15.6.3.4.3.
Positional Sleep Apnea Therapy 15.6.3.4.4. Assess Sleep
Architecture and Continuity 15.6.3.4.5. Others
15.6.4.1.
Kuwait EEG Devices
for Sleep and Sleep Architecture Market Revenue (US$
Mn) and Forecasts, By Channels
15.6.4.1.1.
1 Channel
15.6.4.1.2.
4 Channels
15.6.4.1.3.
pay-per-use + 5 or 14 channels
15.6.4.1.4.
8 -16 Channels
15.6.4.1.5.
Above 16 Channels
15.6.4.2.
Kuwait EEG Devices
for Sleep and Sleep Architecture Market Revenue (US$
Mn) and Forecasts, By Offering
15.6.4.2.1.
Products
15.6.4.2.1.1.
Partially or fully Flexible Systems 15.6.4.2.1.2. Headcaps/Headsets
15.6.4.2.1.3.
Fixed Units
15.6.4.2.1.4.
Others
15.6.4.2.2.
Solution and Services
15.6.4.3.
Kuwait EEG Devices
for Sleep and Sleep Architecture Market Revenue (US$
Mn) and Forecasts, By End Use
15.6.4.3.1.
Research and Universities 15.6.4.3.2. In-Home
15.6.4.3.3.
Hospital/Clinics
15.6.4.3.4.
Businesses (Employers)
15.6.4.3.5.
Others
15.6.4.4.
Kuwait EEG Devices
for Sleep and Sleep Architecture Market Revenue (US$
Mn) and Forecasts, By Application
15.6.4.4.1.
Clinical
15.6.4.4.1.1.
Insomnia
15.6.4.4.1.2.
Hypersomnia
15.6.4.4.1.3.
Other non-OSA sleep disorders
15.6.4.4.2. Research
15.6.4.4.2.1.
REM sleep without
Atonia in patients
with RBD
15.6.4.4.2.2.
Prodromal sleep biomarkers for neurodegenerative
disease
15.6.4.4.2.3.
Effect of Suvorexant progressive supranuclear
palsy
15.6.4.4.2.4.
Sleep patterns in patients with ICU delirium
15.6.4.4.2.5.
Sleep quality changes
as a result of cannabis
and opioid dependency
15.6.4.4.2.6.
Outcomes resulting from an insomnia
intervention 15.6.4.4.2.7. Influence of sleep deprivation on memory
15.6.4.4.2.8. Others
15.6.4.4.3.
Positional Sleep Apnea Therapy 15.6.4.4.4. Assess Sleep
Architecture and Continuity 15.6.4.4.5. Others
15.6.5. South Africa
15.6.5.1.
South Africa EEG Devices for Sleep and Sleep Architecture Market Revenue (US$ Mn) and Forecasts, By Channels
15.6.5.1.1.
1 Channel
15.6.5.1.2.
4 Channels
15.6.5.1.3.
pay-per-use + 5 or 14 channels
15.6.5.1.4.
8 -16 Channels
15.6.5.1.5.
Above 16 Channels
15.6.5.2.
South Africa EEG Devices for Sleep and Sleep Architecture Market Revenue (US$ Mn) and Forecasts, By Offering
15.6.5.2.1.
Products
15.6.5.2.1.1.
Partially or fully Flexible Systems 15.6.5.2.1.2. Headcaps/Headsets
15.6.5.2.1.3.
Fixed Units
15.6.5.2.1.4.
Others
15.6.5.2.2.
Solution and Services
15.6.5.3.
South Africa EEG Devices for Sleep and Sleep Architecture Market Revenue (US$ Mn) and Forecasts, By End Use
15.6.5.3.1.
Research and Universities 15.6.5.3.2. In-Home
15.6.5.3.3.
Hospital/Clinics
15.6.5.3.4.
Businesses (Employers)
15.6.5.3.5.
Others
15.6.5.4.
South Africa EEG Devices for Sleep and Sleep Architecture Market Revenue (US$ Mn) and Forecasts, By Application
15.6.5.4.1.
Clinical
15.6.5.4.1.1.
Insomnia
15.6.5.4.1.2.
Hypersomnia
15.6.5.4.1.3.
Other non-OSA sleep disorders
15.6.5.4.2. Research
15.6.5.4.2.1.
REM sleep without
Atonia in patients
with RBD
15.6.5.4.2.2.
Prodromal sleep biomarkers for neurodegenerative
disease
15.6.5.4.2.3.
Effect of Suvorexant progressive supranuclear
palsy
15.6.5.4.2.4.
Sleep patterns in patients with ICU delirium 15.6.5.4.2.5. Sleep quality changes
as a result of cannabis
and
opioid dependency
15.6.5.4.2.6. Outcomes
resulting from an insomnia intervention 15.6.5.4.2.7. Influence of
sleep deprivation on memory 15.6.5.4.2.8. Others
15.6.5.4.3.
Positional Sleep Apnea Therapy 15.6.5.4.4. Assess Sleep
Architecture and Continuity 15.6.5.4.5. Others
15.6.6. Rest of Middle East & Africa
15.6.6.1.
Rest of Middle
East & Africa
EEG Devices for Sleep and Sleep Architecture Market Revenue (US$ Mn) and
Forecasts, By Channels
15.6.6.1.1.
1 Channel
15.6.6.1.2.
4 Channels
15.6.6.1.3.
pay-per-use + 5 or 14 channels
15.6.6.1.4.
8 -16 Channels
15.6.6.1.5.
Above 16 Channels
15.6.6.2.
Rest of Middle
East & Africa
EEG Devices for Sleep
and Sleep Architecture Market Revenue (US$ Mn) and Forecasts, By Offering
15.6.6.2.1.
Products
15.6.6.2.1.1.
Partially or fully Flexible Systems 15.6.6.2.1.2. Headcaps/Headsets
15.6.6.2.1.3.
Fixed Units
15.6.6.2.1.4.
Others
15.6.6.2.2.
Solution and Services
15.6.6.3.
Rest of Middle
East & Africa
EEG Devices for Sleep and Sleep Architecture Market Revenue (US$ Mn) and
Forecasts, By End Use
15.6.6.3.1.
Research and Universities 15.6.6.3.2. In-Home
15.6.6.3.3.
Hospital/Clinics
15.6.6.3.4.
Businesses (Employers)
15.6.6.3.5.
Others
15.6.6.4.
Rest of Middle
East & Africa
EEG Devices for Sleep and Sleep Architecture Market Revenue (US$ Mn) and
Forecasts, By Application
15.6.6.4.1.
Clinical
15.6.6.4.1.1.
Insomnia
15.6.6.4.1.2.
Hypersomnia
15.6.6.4.1.3.
Other non-OSA sleep disorders
15.6.6.4.2. Research
15.6.6.4.2.1.
REM sleep without
Atonia in patients
with RBD
15.6.6.4.2.2.
Prodromal sleep biomarkers for neurodegenerative
disease
15.6.6.4.2.3.
Effect of Suvorexant progressive supranuclear
palsy
15.6.6.4.2.4.
Sleep patterns in patients with ICU delirium 15.6.6.4.2.5. Sleep
quality changes as a result of cannabis
and
opioid dependency
15.6.6.4.2.6. Outcomes
resulting from an insomnia intervention 15.6.6.4.2.7. Influence of
sleep deprivation on memory 15.6.6.4.2.8. Others
15.6.6.4.3.
Positional Sleep Apnea Therapy 15.6.6.4.4. Assess Sleep
Architecture and Continuity 15.6.6.4.5. Others
15.7.
Key Segment for Channeling Investments
15.7.1.
By Country
15.7.2.
By Channels
15.7.3. By Offering
15.7.4.
By End Use
15.7.5.
By Application
16.
Latin America EEG Devices for Sleep and Sleep
Architecture Market Analysis and Forecasts, 2022 – 2030
16.1.
Overview
16.1.1.
Latin America EEG Devices for Sleep and Sleep
Architecture Market Revenue (US$ Mn)
16.2.
Latin America EEG Devices for Sleep and Sleep
Architecture Market Revenue (US$ Mn) and Forecasts, By
Channels
16.2.1. 1 Channel
16.2.2.
4 Channels
16.2.3. pay-per-use + 5 or 14 channels
16.2.4.
8 -16 Channels
16.2.5. Above 16 Channels
16.3.
Latin America EEG Devices for Sleep and Sleep
Architecture Market Revenue (US$ Mn) and Forecasts, By
Offering
16.3.1. Products
16.3.1.1.
Partially or fully Flexible Systems
16.3.1.2.
Headcaps/Headsets
16.3.1.3.
Fixed Units
16.3.1.4.
Others
16.3.2. Solution and Services
16.4.
Latin America EEG Devices for Sleep and Sleep
Architecture Market Revenue (US$ Mn)
and Forecasts, By End Use
16.4.1. Research and Universities
16.4.2.
In-Home
16.4.3.
Hospital/Clinics
16.4.4.
Businesses (Employers)
16.4.5. Others
16.5.
Latin America EEG Devices for Sleep and Sleep
Architecture Market Revenue (US$ Mn) and Forecasts, By
Application
16.5.1. Clinical
16.5.1.1.
Insomnia
16.5.1.2.
Hypersomnia
16.5.1.3.
Other non-OSA sleep disorders
16.5.2.
Research
16.5.2.1.
REM sleep without
Atonia in patients
with RBD
16.5.2.2.
Prodromal sleep biomarkers for neurodegenerative disease
16.5.2.3.
Effect of Suvorexant progressive supranuclear palsy
16.5.2.4.
Sleep patterns in patients with ICU delirium
16.5.2.5.
Sleep quality changes
as a result of cannabis
and opioid dependency
16.5.2.6.
Outcomes resulting from an insomnia
intervention
16.5.2.7.
Influence of sleep
deprivation on memory
16.5.2.8.
Others
16.5.3.
Positional Sleep Apnea Therapy
16.5.4.
Assess Sleep Architecture and Continuity
16.5.5. Others
16.6.
Latin America EEG Devices for Sleep and Sleep
Architecture Market Revenue (US$ Mn) and Forecasts, By Country
16.6.1. Brazil
16.6.1.1.
Brazil EEG Devices
for Sleep and Sleep Architecture Market Revenue (US$ Mn) and Forecasts, By Channels
16.6.1.1.1.
1 Channel
16.6.1.1.2.
4 Channels
16.6.1.1.3.
pay-per-use + 5 or 14 channels
16.6.1.1.4.
8 -16 Channels
16.6.1.1.5.
Above 16 Channels
16.6.1.2.
Brazil EEG Devices
for Sleep and Sleep Architecture Market Revenue (US$ Mn) and Forecasts, By Offering
16.6.1.2.1.
Products
16.6.1.2.1.1.
Partially or fully Flexible Systems 16.6.1.2.1.2. Headcaps/Headsets
16.6.1.2.1.3.
Fixed Units
16.6.1.2.1.4.
Others
16.6.1.2.2.
Solution and Services
16.6.1.3.
Brazil EEG Devices
for Sleep and Sleep Architecture Market Revenue (US$ Mn) and Forecasts, By End Use
16.6.1.3.1.
Research and Universities 16.6.1.3.2. In-Home
16.6.1.3.3.
Hospital/Clinics
16.6.1.3.4.
Businesses (Employers)
16.6.1.3.5.
Others
16.6.1.4.
Brazil EEG Devices
for Sleep and Sleep Architecture Market Revenue (US$ Mn) and Forecasts, By Application
16.6.1.4.1.
Clinical
16.6.1.4.1.1.
Insomnia
16.6.1.4.1.2.
Hypersomnia
16.6.1.4.1.3.
Other non-OSA sleep disorders
16.6.1.4.2. Research
16.6.1.4.2.1.
REM sleep without
Atonia in patients
with RBD
16.6.1.4.2.2.
Prodromal sleep biomarkers for neurodegenerative
disease
16.6.1.4.2.3.
Effect of Suvorexant progressive supranuclear
palsy
16.6.1.4.2.4.
Sleep patterns in patients with ICU delirium 16.6.1.4.2.5. Sleep
quality changes as a result of cannabis
and
opioid dependency
16.6.1.4.2.6. Outcomes
resulting from an insomnia intervention 16.6.1.4.2.7. Influence of
sleep deprivation on memory 16.6.1.4.2.8. Others
16.6.1.4.3.
Positional Sleep Apnea Therapy 16.6.1.4.4. Assess Sleep
Architecture and Continuity 16.6.1.4.5. Others
16.6.2. Argentina
16.6.2.1.
Argentina EEG Devices
for Sleep and Sleep Architecture Market Revenue (US$
Mn) and Forecasts, By Channels
16.6.2.1.1.
1 Channel
16.6.2.1.2.
4 Channels
16.6.2.1.3.
pay-per-use + 5 or 14 channels
16.6.2.1.4.
8 -16 Channels
16.6.2.1.5.
Above 16 Channels
16.6.2.2.
Argentina EEG Devices
for Sleep and Sleep Architecture Market Revenue (US$
Mn) and Forecasts, By Offering
16.6.2.2.1.
Products
16.6.2.2.1.1.
Partially or fully Flexible Systems 16.6.2.2.1.2. Headcaps/Headsets
16.6.2.2.1.3.
Fixed Units
16.6.2.2.1.4.
Others
16.6.2.2.2.
Solution and Services
16.6.2.3.
Argentina EEG Devices
for Sleep and Sleep Architecture Market Revenue (US$ Mn) and Forecasts, By End Use
16.6.2.3.1.
Research and Universities 16.6.2.3.2. In-Home
16.6.2.3.3.
Hospital/Clinics
16.6.2.3.4.
Businesses (Employers)
16.6.2.3.5.
Others
16.6.2.4.
Argentina EEG Devices
for Sleep and Sleep Architecture Market Revenue (US$
Mn) and Forecasts, By Application
16.6.2.4.1.
Clinical
16.6.2.4.1.1.
Insomnia
16.6.2.4.1.2.
Hypersomnia
16.6.2.4.1.3.
Other non-OSA sleep disorders
16.6.2.4.2. Research
16.6.2.4.2.1.
REM sleep without
Atonia in patients
with RBD
16.6.2.4.2.2.
Prodromal sleep biomarkers for neurodegenerative
disease
16.6.2.4.2.3.
Effect of Suvorexant progressive supranuclear
palsy
16.6.2.4.2.4.
Sleep patterns in patients with ICU delirium 16.6.2.4.2.5. Sleep quality changes
as a result of cannabis
and
opioid dependency
16.6.2.4.2.6. Outcomes
resulting from an insomnia intervention 16.6.2.4.2.7. Influence of
sleep deprivation on memory 16.6.2.4.2.8. Others
16.6.2.4.3.
Positional Sleep Apnea Therapy 16.6.2.4.4. Assess Sleep
Architecture and Continuity 16.6.2.4.5. Others
16.6.3. Rest of Latin America
16.6.3.1.
Rest of Latin
America EEG Devices
for Sleep and Sleep Architecture Market Revenue (US$ Mn) and
Forecasts, By Channels
16.6.3.1.1.
1 Channel
16.6.3.1.2.
4 Channels
16.6.3.1.3.
pay-per-use + 5 or 14 channels
16.6.3.1.4.
8 -16 Channels
16.6.3.1.5.
Above 16 Channels
16.6.3.2.
Rest of Latin
America EEG Devices
for Sleep and Sleep
Architecture Market Revenue (US$ Mn) and Forecasts, By Offering
16.6.3.2.1.
Products
16.6.3.2.1.1.
Partially or fully Flexible Systems 16.6.3.2.1.2. Headcaps/Headsets
16.6.3.2.1.3.
Fixed Units
16.6.3.2.1.4.
Others
16.6.3.2.2.
Solution and Services
16.6.3.3.
Rest of Latin
America EEG Devices
for Sleep and Sleep Architecture Market Revenue (US$ Mn) and
Forecasts, By End Use
16.6.3.3.1.
Research and Universities 16.6.3.3.2. In-Home
16.6.3.3.3.
Hospital/Clinics
16.6.3.3.4.
Businesses (Employers)
16.6.3.3.5.
Others
16.6.3.4.
Rest of Latin
America EEG Devices
for Sleep and Sleep Architecture Market Revenue (US$ Mn) and
Forecasts, By Application
16.6.3.4.1.
Clinical
16.6.3.4.1.1.
Insomnia
16.6.3.4.1.2.
Hypersomnia
16.6.3.4.1.3.
Other non-OSA sleep disorders
16.6.3.4.2. Research
16.6.3.4.2.1.
REM sleep without
Atonia in patients
with RBD
16.6.3.4.2.2.
Prodromal sleep biomarkers for neurodegenerative
disease
16.6.3.4.2.3.
Effect of Suvorexant progressive supranuclear
palsy
16.6.3.4.2.4.
Sleep patterns in patients with ICU delirium 16.6.3.4.2.5. Sleep quality changes
as a result of cannabis
and
opioid dependency
16.6.3.4.2.6. Outcomes
resulting from an insomnia intervention 16.6.3.4.2.7. Influence of
sleep deprivation on memory 16.6.3.4.2.8. Others
16.6.3.4.3.
Positional Sleep Apnea Therapy 16.6.3.4.4. Assess Sleep
Architecture and Continuity 16.6.3.4.5. Others
16.7.
Key Segment for Channeling Investments
16.7.1.
By Country
16.7.2.
By Channels
16.7.3.
By Offering
16.7.4. By End Use
16.7.5.
By Application
17.
Competitive Benchmarking
17.1.
Market Share Analysis, 2021
17.2.
Global Presence and Growth Strategies
17.2.1.
Mergers and Acquisitions
17.2.2. Product Launches
17.2.3.
Investments Trends
17.2.4.
R&D Initiatives
18.
Player Profiles
18.1.
Advanced Brain Monitoring, Inc.
18.1.1. Company Details
18.1.2.
Company Overview
18.1.3.
Product Offerings
18.1.4.
Key Developments
18.1.5. Financial Analysis
18.1.6.
SWOT Analysis
18.1.7.
Business Strategies
18.2.
Cognionics
18.2.1.
Company Details
18.2.2.
Company Overview
18.2.3.
Product Offerings
18.2.4.
Key Developments
18.2.5. Financial Analysis
18.2.6.
SWOT Analysis
18.2.7. Business Strategies
18.3.
Dreem
18.3.1.
Company Details
18.3.2.
Company Overview
18.3.3. Product Offerings
18.3.4.
Key Developments
18.3.5.
Financial Analysis
18.3.6. SWOT Analysis
18.3.7.
Business Strategies
18.4.
Emotiv
18.4.1.
Company Details
18.4.2.
Company Overview
18.4.3.
Product Offerings
18.4.4. Key Developments
18.4.5.
Financial Analysis
18.4.6.
SWOT Analysis
18.4.7.
Business Strategies
18.5.
Muse
18.5.1. Company Details
18.5.2.
Company Overview
18.5.3. Product Offerings
18.5.4.
Key Developments
18.5.5.
Financial Analysis
18.5.6.
SWOT Analysis
18.5.7. Business Strategies
18.6.
NeuroSky
18.6.1.
Company Details
18.6.2.
Company Overview
18.6.3.
Product Offerings
18.6.4. Key Developments
18.6.5.
Financial Analysis
18.6.6.
SWOT Analysis
18.6.7. Business Strategies
18.7.
OpenBCI
18.7.1.
Company Details
18.7.2.
Company Overview
18.7.3. Product Offerings
18.7.4.
Key Developments
18.7.5.
Financial Analysis
18.7.6. SWOT Analysis
18.7.7.
Business Strategies
18.8.
Other Market Participants
19.
Key Findings
Note: This ToC is tentative and can be changed according to the research
study conducted during the course of report completion.
**Exclusive for Multi-User and Enterprise User.
At Absolute Markets Insights, we are engaged in building both global as well as country specific reports. As a result, the approach taken for deriving the estimation and forecast for a specific country is a bit unique and different in comparison to the global research studies. In this case, we not only study the concerned market factors & trends prevailing in a particular country (from secondary research) but we also tend to calculate the actual market size & forecast from the revenue generated from the market participants involved in manufacturing or distributing the any concerned product. These companies can also be service providers. For analyzing any country specifically, we do consider the growth factors prevailing under the states/cities/county for the same. For instance, if we are analyzing an industry specific to United States, we primarily need to study about the states present under the same(where the product/service has the highest growth). Similar analysis will be followed by other countries. Our scope of the report changes with different markets.
Our research study is mainly implement through a mix of both secondary and primary research. Various sources such as industry magazines, trade journals, and government websites and trade associations are reviewed for gathering precise data. Primary interviews are conducted to validate the market size derived from secondary research. Industry experts, major manufacturers and distributors are contacted for further validation purpose on the current market penetration and growth trends.
Prominent participants in our primary research process include:
- Key Opinion Leaders namely the CEOs, CSOs, VPs, purchasing managers, amongst others
- Research and development participants, distributors/suppliers and subject matter experts
Secondary Research includes data extracted from paid data sources:
- Reuters
- Factiva
- Bloomberg
- One Source
- Hoovers
Research Methodology
Key Inclusions
Reach to us
Call us on
+91-74002-42424
Drop us an email at
sales@absolutemarketsinsights.com
Why Absolute Markets Insights?
An effective strategy is the entity that influences a business to stand out of the crowd. An organization with a phenomenal strategy for success dependably has the edge over the rivals in the market. It offers the organizations a head start in planning their strategy. Absolute Market Insights is the new initiation in the industry that will furnish you with the lead your business needs. Absolute Market Insights is the best destination for your business intelligence and analytical solutions; essentially because our qualitative and quantitative sources of information are competent to give one-stop solutions. We inventively combine qualitative and quantitative research in accurate proportions to have the best report, which not only gives the most recent insights but also assists you to grow.